<?xml version="1.0" encoding="UTF-8"?>
<COCHRANE_REVIEW TYPE="INTERVENTION" REVMAN_VERSION="5" ID="000000000000000000" VERSION_NO="3.0" STAGE="R" STATUS="A">
<COVER_SHEET>
<TITLE>Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies [Data only. When citing this record quote "Cochrane Database of Systematic Reviews 2018, Issue 5".]</TITLE>
<CONTACT>
<PERSON ID="3CDBCF5982E26AA2004F2C1C1E0694C2" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Ole Jakob</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Storebø</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Clinical Psychologist</POSITION>
<EMAIL_1>ojst@regionsjaelland.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>+45 2511 9901</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Child and Adolescent Psychiatric Department</DEPARTMENT>
<ORGANISATION>Region Zealand</ORGANISATION>
<ADDRESS_1>Birkevaenget 3</ADDRESS_1>
<ADDRESS_2 />
<CITY>Roskilde</CITY>
<ZIP>4300</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 5948 4735</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
</CONTACT>
<CREATORS>
<PERSON ID="3CDBCF5982E26AA2004F2C1C1E0694C2" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Ole Jakob</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Storebø</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Clinical Psychologist</POSITION>
<EMAIL_1>ojst@regionsjaelland.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>+45 2511 9901</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Child and Adolescent Psychiatric Department</DEPARTMENT>
<ORGANISATION>Region Zealand</ORGANISATION>
<ADDRESS_1>Birkevaenget 3</ADDRESS_1>
<ADDRESS_2 />
<CITY>Roskilde</CITY>
<ZIP>4300</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 5948 4735</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1411181626031577135251356933810" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Nadia</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Pedersen</LAST_NAME>
<SUFFIX />
<POSITION>Pregraduate Research Student</POSITION>
<EMAIL_1>nadia.kordon.pedersen@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1>Toftebakken 9</ADDRESS_1>
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP>4000</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 456 010 3647</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1211011618389049255954533420697" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Erica</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Ramstad</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>erica_ramstad@hotmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1601060927123166136322895260565" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Maja Lærke</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Kielsholm</LAST_NAME>
<SUFFIX>Cand.psych.</SUFFIX>
<POSITION>Pregraduate</POSITION>
<EMAIL_1>supermaja@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>22863842</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1>Fælledvej 6</ADDRESS_1>
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP>4200</ZIP>
<REGION>Sjaelland</REGION>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1601060926118932281509480976450" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Signe Sofie</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Nielsen</LAST_NAME>
<SUFFIX>MA</SUFFIX>
<POSITION />
<EMAIL_1>signesofienielsen@outlook.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1>Fælledvej 6</ADDRESS_1>
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP>4200</ZIP>
<REGION>Sjaelland</REGION>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 585 360 70</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1211121135087371836623855826937" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Helle</FIRST_NAME>
<MIDDLE_INITIALS>B</MIDDLE_INITIALS>
<LAST_NAME>Krogh</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>hellebkrogh@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Child and Adolescent Psychiatric Department</DEPARTMENT>
<ORGANISATION>Region Zealand</ORGANISATION>
<ADDRESS_1>Birkevaenget 3</ADDRESS_1>
<ADDRESS_2 />
<CITY>Roskilde</CITY>
<ZIP>4300</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="75544411639077490763111005102010" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Carlos</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Moreira-Maia</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Post-doctoral researcher</POSITION>
<EMAIL_1>crm.maia@gmail.com</EMAIL_1>
<EMAIL_2>crm.maia@me.com</EMAIL_2>
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Department of Psychiatry</DEPARTMENT>
<ORGANISATION>Federal University of Rio Grande do Sul</ORGANISATION>
<ADDRESS_1>Rua Ramiro Barcelos, 2350-2201A</ADDRESS_1>
<ADDRESS_2 />
<CITY>Porto Alegre</CITY>
<ZIP>90035-003</ZIP>
<REGION>RS</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 51 3359 8094</PHONE_1>
<PHONE_2 />
<FAX_1>+55 51 3359 8094</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1403121355210228686310780647025" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Frederik</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Magnusson</LAST_NAME>
<SUFFIX />
<POSITION>Pregraduate Research Student</POSITION>
<EMAIL_1>f.logstrup@gmail.com</EMAIL_1>
<EMAIL_2>f.logstrup@gmail.com</EMAIL_2>
<URL />
<MOBILE_PHONE>+45 298 7442</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1407011349129973729057441114220" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Mathilde</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Holmskov</LAST_NAME>
<SUFFIX />
<POSITION>Pre-graduate Research Student</POSITION>
<EMAIL_1>mathildeholmskov@gmail.com</EMAIL_1>
<EMAIL_2>mathildeholmskov@gmail.com</EMAIL_2>
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 274 188 65</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1309121150487227977035132278311" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Trine</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Gerner</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>tnilausen@gmail.com</EMAIL_1>
<EMAIL_2>tnilausen@gmail.com</EMAIL_2>
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="F33F439D82E26AA2012E60F3BB0334D4" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Maria</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Skoog</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>maria@skoog.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>+46 (0)730 327001</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Clinical Study Support</DEPARTMENT>
<ORGANISATION>Clinical Studies Sweden - Forum South</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Lund</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="SE">Sweden</COUNTRY>
<PHONE_1>+46 (0)730 327001</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="27504051512687949534110105102719" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Susanne</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Rosendal</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>susanne.rosendal@regionh.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>+45 602220</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT />
<ORGANISATION>Psychiatric Centre North Zealand</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>The Capital Region of Denmark</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 3545 7859</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="32372500100836045400110105103934" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Camilla</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Groth</LAST_NAME>
<SUFFIX />
<POSITION>PhD Student</POSITION>
<EMAIL_1>camilla.groth.jakobsen@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>+45 2335 1768</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Pediatric Department</DEPARTMENT>
<ORGANISATION>Herlev University Hospital</ORGANISATION>
<ADDRESS_1>Capital Region</ADDRESS_1>
<ADDRESS_2 />
<CITY>Herlev</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 5948 4770</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="19546" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Donna</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Gillies</LAST_NAME>
<SUFFIX />
<POSITION>Editor</POSITION>
<EMAIL_1>donnamgillies@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT />
<ORGANISATION />
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Sydney</CITY>
<ZIP />
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 417 221 004</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="02600064331671014335110411163028" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Kirsten</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Buch Rasmussen</LAST_NAME>
<SUFFIX />
<POSITION>Librarian/Information Specialist</POSITION>
<EMAIL_1>kirsten@kodehoved.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+45 47 32 79 08</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="04088408649218978146111107102622" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Dorothy</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Gauci</LAST_NAME>
<SUFFIX />
<POSITION>Statistician / Research Officer</POSITION>
<EMAIL_1>dorothy_gauci@yahoo.co.uk</EMAIL_1>
<EMAIL_2>dorothy.gauci@gov.mt</EMAIL_2>
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Directorate for Health Information and Research</DEPARTMENT>
<ORGANISATION>Department of Health</ORGANISATION>
<ADDRESS_1>95 G'Mangia Hill</ADDRESS_1>
<ADDRESS_2 />
<CITY>G'Mangia</CITY>
<ZIP>PTA 1313</ZIP>
<REGION />
<COUNTRY CODE="MT">Malta</COUNTRY>
<PHONE_1>+356 25599341</PHONE_1>
<PHONE_2>+356 25599000</PHONE_2>
<FAX_1>+356 25599385</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="13333" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Morris</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Zwi</LAST_NAME>
<SUFFIX />
<POSITION>Consultant Child &amp; Adolescent Psychiatrist</POSITION>
<EMAIL_1>mzwi@nhs.net</EMAIL_1>
<EMAIL_2>mzwi@btinternet.com</EMAIL_2>
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Islington Child and Adolescent Mental Health Service</DEPARTMENT>
<ORGANISATION>Whittington Health</ORGANISATION>
<ADDRESS_1>580 Holloway Road</ADDRESS_1>
<ADDRESS_2 />
<CITY>London</CITY>
<ZIP>N7 6LB</ZIP>
<REGION>London</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 3316 1824</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="DF4BD88882E26AA20125F76B55DDF1ED" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Richard</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Kirubakaran</LAST_NAME>
<SUFFIX />
<POSITION>Biostatistician</POSITION>
<EMAIL_1>richrichigo@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>91-9500292922</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Cochrane South Asia, Prof. BV Moses Centre for Evidence-Informed Healthcare and Health Policy</DEPARTMENT>
<ORGANISATION>Christian Medical College</ORGANISATION>
<ADDRESS_1>Carman Block II Floor</ADDRESS_1>
<ADDRESS_2>CMC Campus, Bagayam</ADDRESS_2>
<CITY>Vellore</CITY>
<ZIP>632002</ZIP>
<REGION />
<COUNTRY CODE="IN">India</COUNTRY>
<PHONE_1>91-9500292922</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1504131018425699626188176883597" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Sasja</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Håkonsen</LAST_NAME>
<SUFFIX />
<POSITION>PhD student</POSITION>
<EMAIL_1>sjh@cfkr.info</EMAIL_1>
<EMAIL_2>sjh@kliniskeretningslinjer.dk</EMAIL_2>
<URL />
<MOBILE_PHONE>+45 616 772 68</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Health Science and Technology</DEPARTMENT>
<ORGANISATION>Aalborg University</ORGANISATION>
<ADDRESS_1>Niels Jernes Vej 14</ADDRESS_1>
<ADDRESS_2 />
<CITY>Aalborg</CITY>
<ZIP>9220</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1504131019464272904813838700156" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Lise</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Aagaard</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Assistant Attorney at law</POSITION>
<EMAIL_1>laa@advo.dk</EMAIL_1>
<EMAIL_2>lwg143@alumni.ku.dk</EMAIL_2>
<URL />
<MOBILE_PHONE>+45 244 978 41</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT />
<ORGANISATION>Havemann Law Firm</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Copenhagen</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>45 24497841</PHONE_1>
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="471D7C5282E26AA2004F2C1CC6F0E04C" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Erik</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Simonsen</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>es@regionsjaelland.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Psychiatric Research Unit</DEPARTMENT>
<ORGANISATION>Region Zealand Psychiatry</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Slagelse</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="6439" ROLE="AUTHOR">
<PREFIX />
<FIRST_NAME>Christian</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Gluud</LAST_NAME>
<SUFFIX>M.D, Dr. Med. Sci.</SUFFIX>
<POSITION>Head of Department</POSITION>
<EMAIL_1>cgluud@ctu.dk</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Cochrane Hepato-Biliary Group</DEPARTMENT>
<ORGANISATION>Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital</ORGANISATION>
<ADDRESS_1>Blegdamsvej 9</ADDRESS_1>
<ADDRESS_2 />
<CITY>Copenhagen</CITY>
<ZIP>DK-2100</ZIP>
<REGION />
<COUNTRY CODE="DK">Denmark</COUNTRY>
<PHONE_1>+ 45 3545 7175</PHONE_1>
<PHONE_2 />
<FAX_1>+ 45 3545 7101</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
</CREATORS>
<DATES>
<UP_TO_DATE>
<DATE DAY="" MONTH="" YEAR="" />
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="" MONTH="" YEAR="" />
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR="" />
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR="" />
<REVIEW_PUBLISHED ISSUE="" YEAR="" />
<LAST_CITATION_ISSUE ISSUE="" YEAR="" />
</DATES>
<WHATS_NEW />
<HISTORY />
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES />
<EXTERNAL_SOURCES />
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO" />
<KEYWORDS />
</COVER_SHEET>
<MAIN_TEXT>
<SUMMARY>
<TITLE>Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects</TITLE>
<SUMMARY_BODY>
<P><B>Review question</B></P>
<P>Is methylphenidate administration associated with harmful effects in children and adolescents with attention deficit hyperactivity disorder (ADHD)?</P>
<P><B>Background</B></P>
<P>ADHD is one of the most common neurodevelopmental disorders in childhood and is associated with impaired functioning and negative outcomes for development. Individuals diagnosed with ADHD are often hyperactive and impulsive. Methylphenidate, a psychostimulant, is the drug most often prescribed for children and adolescents with ADHD.</P>
<P><B>Study characteristics</B></P>
<P>We searched for available research up to January 2016 and found 260 studies with different designs. We included a number of non-randomised designs (where investigators did not assign participants to a certain treatment):</P>
<P>– 7 comparative cohort studies (a group of people followed over time; six studies compared 968 patients who were taking methylphenidate to 166 controls who were not taking methylphenidate; and 1 study included 1224 patients that were taking or not taking methylphenidate during different time periods);<BR />
– 4 patient-control studies (comparing two groups of people: 53,192 were taking methylphenidate, and 19,906 were not);<BR />
– 177 non-comparative cohort studies (2,207,751 participants) with no control group (i.e. who were not taking methylphenidate);<BR />
– 2 cross-sectional studies (96 participants were taking methylphenidate at a single time point); and<BR />
– 70 patient reports/series (206 participants were taking methylphenidate).</P>
<P>We also included methylphenidate groups from randomised clinical trials (RCTs; experiments in which participants are randomly put into independent groups that compare different treatments). All RCTs assessed methylphenidate versus other interventions for ADHD and follow-up periods from RCTs. We only used the data from the intervention arm with methylphenidate. In all the included non-comparative cohort studies, 2,207,751 participants were taking methylphenidate. Participants' ages ranged from 3 years to 20 years.</P>
<P><B>Key results</B></P>
<P>The findings suggest that methylphenidate administration might lead to serious adverse (harmful) events, including death, cardiac problems, and psychotic disorders. About 1 in 100 patients treated with methylphenidate seemed to suffer a serious adverse event. Withdrawal from methylphenidate due to serious adverse events occurred in about 1.2 out of 100 patients treated with methylphenidate. Withdrawal from methylphenidate due to any adverse events occurred in about 7.3 out of 100 patients treated with methylphenidate. We also noted a large proportion of non-serious adverse events. More than half the patients exposed to methylphenidate seemed to suffer one or more adverse events. Withdrawal from methylphenidate due to non-serious adverse events occurred in about 6.2 out of 100 patients exposed to methylphenidate. Withdrawal of methylphenidate for unknown reasons was 16.2 out of 100 patients exposed to methylphenidate.</P>
<P><B>Quality of the evidence</B></P>
<P>The quality of the evidence and hence the certainty or reliability of the evidence for the comparative studies is very low. The reliability of the evidence for the non-comparative studies is low due to weaknesses in study design. Accordingly, it is not possible to accurately estimate the risks of adverse events in children and adolescents prescribed methylphenidate.</P>
<P><B>Conclusions</B></P>
<P>Methyphenidiate might be associated with a number of serious adverse events. Methylphenidate produces a large number of other non-serious harmful effects in children and adolescents with ADHD. We suggest that clinicians and parents are alert to the importance of monitoring adverse events in a systematic, meticulous manner. If methylphenidate is to continue to have a place in ADHD treatment in the future, we need to identify subgroups of patients in whom the benefits of methylphenidate outweigh the harms. Just as we need to be able to identify who is likely to benefit from treatment, we also need to be able to identify those who are most at risk of experiencing adverse events. In order to do this, we need to undertake large-scale, high-quality RCTs along with other studies aimed at identifying those who respond and those who do not respond to treatment.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P />
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P />
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P />
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P />
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P />
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P />
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P />
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P />
<CONDITION>
<P />
</CONDITION>
<INTERVENTION>
<P />
</INTERVENTION>
<THEORY>
<P />
</THEORY>
<IMPORTANCE>
<P />
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P />
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P />
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P />
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P />
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P />
<CRIT_OUTCOMES_PRIMARY>
<P />
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY>
<P />
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P />
<ELECTRONIC_SEARCHES>
<P />
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES>
<P />
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P />
<STUDY_SELECTION>
<P />
</STUDY_SELECTION>
<DATA_EXTRACTION>
<P />
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT>
<P />
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES>
<P />
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS>
<P />
</UNIT_OF_ANALYSIS>
<MISSING_DATA>
<P />
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT>
<P />
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT>
<P />
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS>
<P />
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS>
<P />
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS>
<P />
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P />
<SEARCH_RESULTS>
<P />
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR>
<P />
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR>
<P />
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P />
<ALLOCATION>
<P />
</ALLOCATION>
<BLINDING>
<P />
</BLINDING>
<EXCLUSIONS>
<P />
</EXCLUSIONS>
<SELECTIVE_REPORTING>
<P />
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES>
<P />
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P />
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P />
<SUMMARY_OF_RESULTS>
<P />
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS>
<P />
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE>
<P />
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES>
<P />
</POTENTIAL_BIASES>
<AGREEMENT>
<P />
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P />
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P />
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P />
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P />
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P />
</CONTRIBUTIONS>
<PRO_REV_DIFF>
<P />
</PRO_REV_DIFF>
<PUBLIC_NOTES>
<P />
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Abali-2007" NAME="Abali 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abbas-2006" NAME="Abbas 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abbasi-2011" NAME="Abbasi 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Adrian-2001" NAME="Adrian 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Agarwal-2008" NAME="Agarwal 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aguilera_x002d_Albesa-2010" NAME="Aguilera-Albesa 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akhondzadeh-2003" NAME="Akhondzadeh 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akhondzadeh-2004" NAME="Akhondzadeh 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alpaslan-2015" NAME="Alpaslan 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Altin-2013" NAME="Altin 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amiri-2008" NAME="Amiri 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arabgol-2015" NAME="Arabgol 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ardic-2014" NAME="Ardic 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arman-2013" NAME="Arman 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arnold-2004" NAME="Arnold 2004" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arnold-2010" NAME="Arnold 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Artul-2014" NAME="Artul 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arun-2014" NAME="Arun 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ashkenasi-2011" NAME="Ashkenasi 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Atzori-2009" NAME="Atzori 2009" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ayaz-2014" NAME="Ayaz 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bal_x00e1_zs-2011" NAME="Balázs 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barbaresi-2006" NAME="Barbaresi 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barrickman-1995" NAME="Barrickman 1995" YEAR="1995">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berek-2011" NAME="Berek 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bereket-2005" NAME="Bereket 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernhard-2009" NAME="Bernhard 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blader-2010" NAME="Blader 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buchmann-2007" NAME="Buchmann 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cakin_x002d_Memik-2010" NAME="Cakin-Memik 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00c7_etin-2015" NAME="Çetin 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chandler-1989" NAME="Chandler 1989" YEAR="1989">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chazan-2011" NAME="Chazan 2011" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cherland-1999" NAME="Cherland 1999" YEAR="1999">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cho-2012" NAME="Cho 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chou-2012a" NAME="Chou 2012a" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chou-2012b" NAME="Chou 2012b" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cockcroft-2009" NAME="Cockcroft 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-1992" NAME="Cohen 1992" YEAR="1992">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coignoux-2009" NAME="Coignoux 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Confino_x002d_Cohen-2005" NAME="Confino-Cohen 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Congologlu-2009" NAME="Congologlu 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corrigall-1996" NAME="Corrigall 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cortese-2015" NAME="Cortese 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Co_x015f_kun-2008" NAME="Coşkun 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Co_x015f_kun-2009a" NAME="Coşkun 2009a" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Co_x015f_kun-2009b" NAME="Coşkun 2009b" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Co_x015f_kun-2010" NAME="Coşkun 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Co_x015f_kun-2011" NAME="Coşkun 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davari_x002d_Ashtiani-2010" NAME="Davari-Ashtiani 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delignieres-2011" NAME="Delignieres 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dirksen-2002" NAME="Dirksen 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dittmann-2014" NAME="Dittmann 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dodangi-2011" NAME="Dodangi 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER" NAME="Döpfner 2011a, OBSEER" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x00f6_pfner-2011b" NAME="Döpfner 2011b" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x00f6_pfner-2011c" NAME="Döpfner 2011c" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dubnov_x002d_Raz-2011" NAME="Dubnov-Raz 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dupuy-2008" NAME="Dupuy 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dur_x00e1__x002d_Trav_x00e9_-2012" NAME="Durá-Travé 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Efron-1997" NAME="Efron 1997" YEAR="1997">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Fiky-2014" NAME="El-Fiky 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Zein-2005" NAME="El-Zein 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Famularo-1987" NAME="Famularo 1987" YEAR="1987">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faraone-2007a" NAME="Faraone 2007a" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feeney-1997" NAME="Feeney 1997" YEAR="1997">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fern_x00e1_ndez_x002d_Fern_x00e1_ndez-2010" NAME="Fernández-Fernández 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fern_x00e1_ndez_x002d_Fern_x00e1_ndez-2011" NAME="Fernández-Fernández 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Findling-1996" NAME="Findling 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Findling-2009" NAME="Findling 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Findling-2010" NAME="Findling 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gadow-1995" NAME="Gadow 1995" YEAR="1995">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galland-2010" NAME="Galland 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-2014" NAME="Garg 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gau-2006" NAME="Gau 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gau-2008" NAME="Gau 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Germinario-2013" NAME="Germinario 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerwe-2009" NAME="Gerwe 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2008a" NAME="Ghanizadeh 2008a" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2008b" NAME="Ghanizadeh 2008b" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2008c" NAME="Ghanizadeh 2008c" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2009" NAME="Ghanizadeh 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2012" NAME="Ghanizadeh 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghanizadeh-2013" NAME="Ghanizadeh 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goetz-2011" NAME="Goetz 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goez-2012" NAME="Goez 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-G_x00f6_kce-2015" NAME="Gökce 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Golubchik-2011" NAME="Golubchik 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gracious-1999" NAME="Gracious 1999" YEAR="1999">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grcevich-2001" NAME="Grcevich 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-2011" NAME="Green 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Greenberg-1987" NAME="Greenberg 1987" YEAR="1987">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Greenhill-1983" NAME="Greenhill 1983" YEAR="1983">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grossman-1985" NAME="Grossman 1985" YEAR="1985">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gross_x002d_Tsur-2004" NAME="Gross-Tsur 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gucuyener-2003" NAME="Gucuyener 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guerreiro-1996" NAME="Guerreiro 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haertling-2015" NAME="Haertling 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halevy-2009" NAME="Halevy 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammerness-2009" NAME="Hammerness 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammerness-2012" NAME="Hammerness 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haubold-2010" NAME="Haubold 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hazell-2003" NAME="Hazell 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hechtman-2011" NAME="Hechtman 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hemmer-2001" NAME="Hemmer 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollis-2007" NAME="Hollis 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holtkamp-2002" NAME="Holtkamp 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong-2012" NAME="Hong 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hulvershorn-2012" NAME="Hulvershorn 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ilgenli-2007" NAME="Ilgenli 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irmak-2014" NAME="Irmak 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-I_x015f_eri-2007" NAME="Işeri 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jafarinia-2012" NAME="Jafarinia 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-1999-_x0028_MTA_x0029_" NAME="Jensen 1999 (MTA)" YEAR="1999">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-2013" NAME="Johnson 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jung-2007" NAME="Jung 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karabekiroglu-2008" NAME="Karabekiroglu 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karaman-2010" NAME="Karaman 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karapinar-2014" NAME="Karapinar 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kazanci-2015" NAME="Kazanci 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kemner-2005-_x0028_FOCUS_x0029_" NAME="Kemner 2005 (FOCUS)" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khajehpiri-2014" NAME="Khajehpiri 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khodadust-2012" NAME="Khodadust 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2010" NAME="Kim 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2011" NAME="Kim 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2014a" NAME="Kim 2014a" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2014b" NAME="Kim 2014b" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2015a" NAME="Kim 2015a" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2015b" NAME="Kim 2015b" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klein-2004" NAME="Klein 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kordon-2011" NAME="Kordon 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kratochvil-2002" NAME="Kratochvil 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kraut-2013" NAME="Kraut 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lahat-2000" NAME="Lahat 2000" YEAR="2000">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lakic-2012" NAME="Lakic 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lamberti-2015" NAME="Lamberti 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Langevin-2012" NAME="Langevin 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larra_x00f1_aga_x002d_Fragoso-2015" NAME="Larrañaga-Fragoso 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2007" NAME="Lee 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2009" NAME="Lee 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2012" NAME="Lee 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2014" NAME="Lee 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-2012" NAME="Lewis 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2011" NAME="Li 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lyon-2010" NAME="Lyon 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maayan-2009" NAME="Maayan 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacDonald-2005" NAME="MacDonald 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Machado-2010" NAME="Machado 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maia-2008" NAME="Maia 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Man-2015" NAME="Man 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayes-1994" NAME="Mayes 1994" YEAR="1994">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCarthy-2009" NAME="McCarthy 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCracken-2016" NAME="McCracken 2016" YEAR="2016">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McLaren-2010" NAME="McLaren 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller_x002d_Horn-2008" NAME="Miller-Horn 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mino-1999" NAME="Mino 1999" YEAR="1999">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mize-2004" NAME="Mize 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohammadi-2004" NAME="Mohammadi 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohammadi-2009" NAME="Mohammadi 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohammadi-2010" NAME="Mohammadi 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohammadi-2012a" NAME="Mohammadi 2012a" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohammadi-2012b" NAME="Mohammadi 2012b" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monta_x00f1__x00e9_s_x002d_Rada-2012" NAME="Montañés-Rada 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montiel_x002d_Nava-2002" NAME="Montiel-Nava 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moungnoi-2011" NAME="Moungnoi 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Munk-2015" NAME="Munk 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Na-2013" NAME="Na 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niederhofer-2009" NAME="Niederhofer 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niederhofer-2011" NAME="Niederhofer 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nymark-2008" NAME="Nymark 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_zcan-2004" NAME="Özcan 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2013" NAME="Park 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perera-2010" NAME="Perera 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peyre-2012a" NAME="Peyre 2012a" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pierce-2010" NAME="Pierce 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Polanczyk-2007" NAME="Polanczyk 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porfirio-2011" NAME="Porfirio 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poulton-2003" NAME="Poulton 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poulton-2012" NAME="Poulton 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramasamy-2014" NAME="Ramasamy 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rappaport-2004" NAME="Rappaport 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rapport-1996" NAME="Rapport 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rashid-2007" NAME="Rashid 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Remschmidt-2005" NAME="Remschmidt 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ririe-1997" NAME="Ririe 1997" YEAR="1997">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sabuncuoglu-2007" NAME="Sabuncuoglu 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sahin-2014" NAME="Sahin 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saieh-2004" NAME="Saieh 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sangal-2006" NAME="Sangal 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santosh-2006" NAME="Santosh 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schertz-1996" NAME="Schertz 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-2002" NAME="Schmidt 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schulz-2010" NAME="Schulz 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2004" NAME="Schwartz 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shang-2015" NAME="Shang 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shibib-2009" NAME="Shibib 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shin-2016" NAME="Shin 2016" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shyu-2015" NAME="Shyu 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silva-2004" NAME="Silva 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sobanski-2013" NAME="Sobanski 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2012" NAME="Song 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spencer-1992" NAME="Spencer 1992" YEAR="1992">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steele-2006" NAME="Steele 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-2002" NAME="Stein 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevens-2010" NAME="Stevens 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strandell-2007" NAME="Strandell 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2015" NAME="Su 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sudarmadji-2009" NAME="Sudarmadji 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2010" NAME="Tang 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tasdelen-2015" NAME="Tasdelen 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tekin-2015" NAME="Tekin 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorell-2009" NAME="Thorell 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tom_x00e1_s-Vila-2010a" NAME="Tomás Vila 2010a" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tom_x00e1_s-Vila-2010b" NAME="Tomás Vila 2010b" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trugman-1988" NAME="Trugman 1988" YEAR="1988">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tzang-2012" NAME="Tzang 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-T_x00f8_ll_x00f8_fsrud-2006" NAME="Tølløfsrud 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004" NAME="Valdizán Usón 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013" NAME="Valdizán Usón 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-der-Oord-2007" NAME="Van der Oord 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Varley-2001" NAME="Varley 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vashi-2011" NAME="Vashi 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verret-2010" NAME="Verret 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vincent-1990" NAME="Vincent 1990" YEAR="1990">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walitza-2007" NAME="Walitza 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walitza-2009" NAME="Walitza 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007" NAME="Wang 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2011" NAME="Wang 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warshaw-2010" NAME="Warshaw 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weber-2003" NAME="Weber 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2007" NAME="Weiss 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wigal-2011" NAME="Wigal 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wigal-2013" NAME="Wigal 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wigal-2015" NAME="Wigal 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiguna-2012" NAME="Wiguna 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilens-2005" NAME="Wilens 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilens-2006" NAME="Wilens 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilens-2008" NAME="Wilens 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2008" NAME="Williams 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williamson-2011" NAME="Williamson 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winsberg-1982" NAME="Winsberg 1982" YEAR="1982">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winterstein-2009" NAME="Winterstein 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Witt-2008" NAME="Witt 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woolley-2003" NAME="Woolley 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yalcin-2012" NAME="Yalcin 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yalcin-2014" NAME="Yalcin 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2004" NAME="Yang 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2012" NAME="Yang 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yatsuga-2014" NAME="Yatsuga 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yildiz-2010" NAME="Yildiz 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yildiz-2011" NAME="Yildiz 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yilmaz-2013" NAME="Yilmaz 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2010" NAME="Yu 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zarinara-2010" NAME="Zarinara 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zelnik-2015" NAME="Zelnik 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeni-2007" NAME="Zeni 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2010" NAME="Zhang 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-2011" NAME="Zheng 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-2015" NAME="Zheng 2015" YEAR="2015">
<IDENTIFIERS />
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES />
<AWAITING_STUDIES />
<ONGOING_STUDIES />
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES />
<OTHER_VERSIONS_REFERENCES />
<PENDING_REFERENCES />
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Abali-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Abbas-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Abbasi-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Adrian-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Agarwal-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Aguilera_x002d_Albesa-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Akhondzadeh-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Akhondzadeh-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Alpaslan-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Altin-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Amiri-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arabgol-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ardic-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arman-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arnold-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arnold-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Artul-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arun-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ashkenasi-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Atzori-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ayaz-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bal_x00e1_zs-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Barbaresi-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Barrickman-1995">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Berek-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bereket-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bernhard-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Blader-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Buchmann-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cakin_x002d_Memik-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chandler-1989">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chazan-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cherland-1999">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cho-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chou-2012a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chou-2012b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cockcroft-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cohen-1992">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Coignoux-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Confino_x002d_Cohen-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Congologlu-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Corrigall-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cortese-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Co_x015f_kun-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Co_x015f_kun-2009a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Co_x015f_kun-2009b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Co_x015f_kun-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Co_x015f_kun-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Delignieres-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dirksen-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dittmann-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dodangi-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dubnov_x002d_Raz-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dupuy-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dur_x00e1__x002d_Trav_x00e9_-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-D_x00f6_pfner-2011b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-D_x00f6_pfner-2011c">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Efron-1997">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-El_x002d_Fiky-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-El_x002d_Zein-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Famularo-1987">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Faraone-2007a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Feeney-1997">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fern_x00e1_ndez_x002d_Fern_x00e1_ndez-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fern_x00e1_ndez_x002d_Fern_x00e1_ndez-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Findling-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Findling-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Findling-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gadow-1995">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Galland-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Garg-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gau-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gau-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Germinario-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gerwe-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2008a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2008b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2008c">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ghanizadeh-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Goetz-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Goez-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Golubchik-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gracious-1999">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Grcevich-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Green-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Greenberg-1987">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Greenhill-1983">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gross_x002d_Tsur-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Grossman-1985">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gucuyener-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Guerreiro-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-G_x00f6_kce-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Haertling-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Halevy-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hammerness-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hammerness-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Haubold-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hazell-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hechtman-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hemmer-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hollis-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Holtkamp-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hong-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hulvershorn-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ilgenli-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Irmak-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-I_x015f_eri-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jafarinia-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Johnson-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jung-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Karabekiroglu-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Karaman-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Karapinar-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kazanci-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Khajehpiri-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Khodadust-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2014a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2014b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2015a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kim-2015b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Klein-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kordon-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kratochvil-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kraut-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lahat-2000">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lakic-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lamberti-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Langevin-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Larra_x00f1_aga_x002d_Fragoso-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lee-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lee-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lee-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lee-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lewis-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Li-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lyon-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Maayan-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-MacDonald-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Machado-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Maia-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Man-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mayes-1994">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McCarthy-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McCracken-2016">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McLaren-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Miller_x002d_Horn-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mino-1999">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mize-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mohammadi-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mohammadi-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mohammadi-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mohammadi-2012a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mohammadi-2012b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Monta_x00f1__x00e9_s_x002d_Rada-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Montiel_x002d_Nava-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Moungnoi-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Munk-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Na-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Niederhofer-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Niederhofer-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Nymark-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Park-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Perera-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Peyre-2012a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pierce-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Polanczyk-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Porfirio-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Poulton-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Poulton-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ramasamy-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rappaport-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rapport-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rashid-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Remschmidt-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ririe-1997">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sabuncuoglu-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sahin-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Saieh-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sangal-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Santosh-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schertz-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schmidt-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schulz-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schwartz-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shang-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shibib-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shin-2016">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shyu-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Silva-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sobanski-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Song-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Spencer-1992">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Steele-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Stein-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Stevens-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Strandell-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Su-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sudarmadji-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tang-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tasdelen-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tekin-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Thorell-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tom_x00e1_s-Vila-2010a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Trugman-1988">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tzang-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-T_x00f8_ll_x00f8_fsrud-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Van-der-Oord-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Varley-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vashi-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Verret-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vincent-1990">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Walitza-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Walitza-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wang-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wang-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Warshaw-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Weber-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Weiss-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wigal-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wigal-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wigal-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wiguna-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wilens-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wilens-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wilens-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Williams-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Williamson-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Winsberg-1982">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Winterstein-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Witt-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Woolley-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yalcin-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yalcin-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yang-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yang-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yatsuga-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yildiz-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yildiz-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yilmaz-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yu-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zarinara-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zelnik-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zeni-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zhang-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zheng-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zheng-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-_x00c7_etin-2015">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-_x00d6_zcan-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS />
<SOF_TABLES />
<ADDITIONAL_TABLES />
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Comparative studies: number of serious adverse events</NAME>
<DICH_OUTCOME CHI2="5.726316557691663E-4" CI_END="1.569191197740161" CI_START="1.1748869541753206" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3578005254203067" ESTIMABLE="YES" EVENTS_1="860" EVENTS_2="229" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.19567586332214387" LOG_CI_START="0.06999608146757112" LOG_EFFECT_SIZE="0.1328359723948575" METHOD="IV" NO="1" P_CHI2="0.9809086657438598" P_Q="1.0" P_Z="3.426003572570607E-5" Q="0.0" RANDOM="YES" SCALE="807.68" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="52851" TOTAL_2="19154" WEIGHT="99.99999999999999" Z="4.143128161163415">
<NAME>Any serious adverse events</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="23.73793776964787" CI_START="0.07236858825170601" EFFECT_SIZE="1.3106796116504855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.375442986978958" LOG_CI_START="-1.14044989939929" LOG_EFFECT_SIZE="0.11749654378983394" ORDER="1291" O_E="0.0" SE="1.477847935329224" STUDY_ID="STD-Hemmer-2001" TOTAL_1="205" TOTAL_2="29" VAR="2.18403451995685" WEIGHT="0.24954366092138228" />
<DICH_DATA CI_END="1.569613737940885" CI_START="1.1747782633317587" EFFECT_SIZE="1.357920506200515" ESTIMABLE="YES" EVENTS_1="856" EVENTS_2="229" LOG_CI_END="0.1957927911863633" LOG_CI_START="0.06995590226819046" LOG_EFFECT_SIZE="0.13287434672727688" ORDER="2717" O_E="0.0" SE="0.07391721145318089" STUDY_ID="STD-Shyu-2015" TOTAL_1="52646" TOTAL_2="19125" VAR="0.005463754149014256" WEIGHT="99.75045633907861" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.726316557691663E-4" CI_END="1.569191197740161" CI_START="1.1748869541753206" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3578005254203067" ESTIMABLE="YES" EVENTS_1="860" EVENTS_2="229" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.19567586332214387" LOG_CI_START="0.06999608146757112" LOG_EFFECT_SIZE="0.1328359723948575" METHOD="IV" NO="2" P_CHI2="0.9809086657438598" P_Q="0.9809086657438598" P_Z="3.426003572570607E-5" Q="5.726316557691663E-4" RANDOM="YES" SCALE="788.6994659583612" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="52851" TOTAL_2="19154" WEIGHT="200.0" Z="4.143128161163415">
<NAME>Central nervous system</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="23.73793776964787" CI_START="0.07236858825170601" DF="0" EFFECT_SIZE="1.3106796116504855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="1.375442986978958" LOG_CI_START="-1.14044989939929" LOG_EFFECT_SIZE="0.11749654378983394" NO="1" P_CHI2="1.0" P_Z="0.8547451287007808" STUDIES="1" TAU2="0.0" TOTAL_1="205" TOTAL_2="29" WEIGHT="100.0" Z="0.1830674075059851">
<NAME>Seizures</NAME>
<DICH_DATA CI_END="23.73793776964787" CI_START="0.07236858825170601" EFFECT_SIZE="1.3106796116504855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.375442986978958" LOG_CI_START="-1.14044989939929" LOG_EFFECT_SIZE="0.11749654378983394" ORDER="1291" O_E="0.0" SE="1.477847935329224" STUDY_ID="STD-Hemmer-2001" TOTAL_1="205" TOTAL_2="29" VAR="2.18403451995685" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.569613737940885" CI_START="1.1747782633317587" DF="0" EFFECT_SIZE="1.357920506200515" ESTIMABLE="YES" EVENTS_1="856" EVENTS_2="229" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.1957927911863633" LOG_CI_START="0.06995590226819046" LOG_EFFECT_SIZE="0.13287434672727688" NO="2" P_CHI2="1.0" P_Z="3.485936601751082E-5" STUDIES="1" TAU2="0.0" TOTAL_1="52646" TOTAL_2="19125" WEIGHT="100.0" Z="4.139150868933162">
<NAME>Psychotic disorder</NAME>
<DICH_DATA CI_END="1.569613737940885" CI_START="1.1747782633317587" EFFECT_SIZE="1.357920506200515" ESTIMABLE="YES" EVENTS_1="856" EVENTS_2="229" LOG_CI_END="0.1957927911863633" LOG_CI_START="0.06995590226819046" LOG_EFFECT_SIZE="0.13287434672727688" ORDER="2717" O_E="0.0" SE="0.07391721145318089" STUDY_ID="STD-Shyu-2015" TOTAL_1="52646" TOTAL_2="19125" VAR="0.005463754149014256" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-001.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Cardiovascular and respiratory system</NAME>
<TR>
<TH>
<P>Effect estimate (risk ratio with 95% confidence intervals)</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.03.01" NO="1" STUDIES="1">
<NAME>Arrhythmias</NAME>
<OTHER_DATA ORDER="5" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>RR 1.61 (95% CI 1.48 to 1.74)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.03.02" NO="2" STUDIES="1">
<NAME>Hypertension</NAME>
<OTHER_DATA ORDER="6" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>RR 1.07 (95% CI 0.94 to 1.22)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.03.03" NO="3" STUDIES="1">
<NAME>Myocardial infarction</NAME>
<OTHER_DATA ORDER="7" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>RR 1.33 (95% CI 0.90 to 1.98)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.03.04" NO="4" STUDIES="1">
<NAME>Ischaemic stroke</NAME>
<OTHER_DATA ORDER="8" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>RR 0.70 (95% CI 0.49 to 1.01)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.03.05" NO="5" STUDIES="1">
<NAME>Heart failure</NAME>
<OTHER_DATA ORDER="9" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>RR 0.54 (95% CI 0.30 to 0.96)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Comparative studies: number of participants with non-serious adverse events</NAME>
<DICH_OUTCOME CHI2="4.19764504220415" CI_END="3.3621007989197897" CI_START="1.1871231657823393" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9978057323205858" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.5266107298525334" LOG_CI_START="0.0744957799863424" LOG_EFFECT_SIZE="0.30055325491943785" METHOD="IV" NO="1" P_CHI2="0.8979289150112042" P_Q="0.777074620632054" P_Z="0.009164459377528165" Q="4.023432340428279" RANDOM="YES" SCALE="931.35" SORT_BY="EFFECT_SIZE" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="396" TOTAL_2="190" WEIGHT="800.0" Z="2.6058574495390063">
<NAME>Central nervous system: sleep-related adverse events</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.17421270177587117" CI_END="5.336667821276059" CI_START="1.2438130461624615" DF="2" EFFECT_SIZE="2.576396137851973" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="7" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.7272701711609928" LOG_CI_START="0.0947551077489731" LOG_EFFECT_SIZE="0.41101263945498295" NO="1" P_CHI2="0.9165796502604797" P_Z="0.01085923722036771" STUDIES="3" TAU2="0.0" TOTAL_1="312" TOTAL_2="113" WEIGHT="100.0" Z="2.547196160600418">
<NAME>Insomnia and sleep problems</NAME>
<DICH_DATA CI_END="5.461771591028466" CI_START="1.0883480370703948" EFFECT_SIZE="2.4380952380952383" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.737333534172424" LOG_CI_START="0.03676779831139914" LOG_EFFECT_SIZE="0.38705066624191153" ORDER="1507" O_E="0.0" SE="0.4115157811010874" STUDY_ID="STD-Stein-2002" TOTAL_1="35" TOTAL_2="32" VAR="0.16934523809523808" WEIGHT="81.51620644232368" />
<DICH_DATA CI_END="22.68535111819216" CI_START="0.33336490850852957" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.355745505555452" LOG_CI_START="-0.47708011789492677" LOG_EFFECT_SIZE="0.43933269383026263" ORDER="786" O_E="0.0" SE="1.07661084384791" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="1.1590909090909092" WEIGHT="11.909662374474879" />
<DICH_DATA CI_END="77.6740668850133" CI_START="0.26507893815895545" EFFECT_SIZE="4.537593984962406" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="1.8902760446869238" LOG_CI_START="-0.5766247777543594" LOG_EFFECT_SIZE="0.6568256334662822" ORDER="866" O_E="0.0" SE="1.449069754458023" STUDY_ID="STD-Tzang-2012" TOTAL_1="265" TOTAL_2="70" VAR="2.0998031532850354" WEIGHT="6.574131183201449" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.207079489513904" CI_START="0.40938618206085636" DF="0" EFFECT_SIZE="1.1458333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.5061097243280136" LOG_CI_START="-0.38786682009070045" LOG_EFFECT_SIZE="0.059121452118656596" NO="2" P_CHI2="1.0" P_Z="0.795452353690314" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="0.25923704059063796">
<NAME>Nightmares</NAME>
<DICH_DATA CI_END="3.207079489513904" CI_START="0.40938618206085636" EFFECT_SIZE="1.1458333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5061097243280136" LOG_CI_START="-0.38786682009070045" LOG_EFFECT_SIZE="0.059121452118656596" ORDER="784" O_E="0.0" SE="0.5251262474468171" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="0.27575757575757576" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="86.71551310991913" CI_START="0.24565126104861093" DF="0" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="1.938096798230107" LOG_CI_START="-0.6096810020764933" LOG_EFFECT_SIZE="0.6642078980768068" NO="3" P_CHI2="1.0" P_Z="0.3068146876001876" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="1.0219286456777594">
<NAME>Snoring</NAME>
<DICH_DATA CI_END="86.71551310991913" CI_START="0.24565126104861093" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.938096798230107" LOG_CI_START="-0.6096810020764933" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="1224" O_E="0.0" SE="1.4965772916036075" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="2.2397435897435893" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="61.65259024353402" CI_START="0.12438470180997305" DF="0" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.01.04" LOG_CI_END="1.7899513275634158" LOG_CI_START="-0.905233030642515" LOG_EFFECT_SIZE="0.4423591484604505" NO="4" P_CHI2="1.0" P_Z="0.5199803810336917" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="0.6433756537466847">
<NAME>Non-breathing or gasping while sleeping</NAME>
<DICH_DATA CI_END="61.65259024353402" CI_START="0.12438470180997305" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7899513275634158" LOG_CI_START="-0.905233030642515" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="1225" O_E="0.0" SE="1.583164633387904" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="2.506410256410256" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="22.68535111819216" CI_START="0.33336490850852957" DF="0" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-002.01.05" LOG_CI_END="1.355745505555452" LOG_CI_START="-0.47708011789492677" LOG_EFFECT_SIZE="0.43933269383026263" NO="5" P_CHI2="1.0" P_Z="0.3474145121699955" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="0.9396161272748484">
<NAME>Sleepwalking</NAME>
<DICH_DATA CI_END="22.68535111819216" CI_START="0.33336490850852957" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.355745505555452" LOG_CI_START="-0.47708011789492677" LOG_EFFECT_SIZE="0.43933269383026263" ORDER="1226" O_E="0.0" SE="1.07661084384791" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="1.1590909090909092" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="61.65259024353402" CI_START="0.12438470180997305" DF="0" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.01.06" LOG_CI_END="1.7899513275634158" LOG_CI_START="-0.905233030642515" LOG_EFFECT_SIZE="0.4423591484604505" NO="6" P_CHI2="1.0" P_Z="0.5199803810336917" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="0.6433756537466847">
<NAME>Various sleep positions</NAME>
<DICH_DATA CI_END="61.65259024353402" CI_START="0.12438470180997305" EFFECT_SIZE="2.769230769230769" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7899513275634158" LOG_CI_START="-0.905233030642515" LOG_EFFECT_SIZE="0.4423591484604505" ORDER="1228" O_E="0.0" SE="1.583164633387904" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="2.506410256410256" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="86.71551310991913" CI_START="0.24565126104861093" DF="0" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.01.07" LOG_CI_END="1.938096798230107" LOG_CI_START="-0.6096810020764933" LOG_EFFECT_SIZE="0.6642078980768068" NO="7" P_CHI2="1.0" P_Z="0.3068146876001876" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="1.0219286456777594">
<NAME>Enuresis</NAME>
<DICH_DATA CI_END="86.71551310991913" CI_START="0.24565126104861093" EFFECT_SIZE="4.615384615384615" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.938096798230107" LOG_CI_START="-0.6096810020764933" LOG_EFFECT_SIZE="0.6642078980768068" ORDER="1230" O_E="0.0" SE="1.4965772916036075" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="2.2397435897435893" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.297289240104781E-33" CI_END="4.377922458882302" CI_START="0.04798382027489721" DF="0" EFFECT_SIZE="0.45833333333333337" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="99.99999999999999" ID="CMP-002.01.08" LOG_CI_END="0.6412680651401439" LOG_CI_START="-1.318905178246906" LOG_EFFECT_SIZE="-0.33881855655338095" NO="8" P_CHI2="0.0" P_Z="0.4980476932554261" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="11" WEIGHT="100.0" Z="0.6775647717657869">
<NAME>Talking in sleep</NAME>
<DICH_DATA CI_END="4.377922458882302" CI_START="0.04798382027489721" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6412680651401439" LOG_CI_START="-1.318905178246906" LOG_EFFECT_SIZE="-0.338818556553381" ORDER="1227" O_E="0.0" SE="1.151415466179596" STUDY_ID="STD-Cockcroft-2009" TOTAL_1="12" TOTAL_2="11" VAR="1.325757575757576" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.253209002242825" CI_END="0.037429296603215034" CI_START="-0.8056747852937394" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.38412274434526217" ESTIMABLE="YES" I2="52.97668186667175" I2_Q="52.97668186667175" ID="CMP-002.02" NO="2" P_CHI2="0.11924155315164153" P_Q="0.11924155315164153" P_Z="0.07410893795305222" Q="4.253209002242825" RANDOM="YES" SCALE="4.73" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.2175826398829936" TOTALS="SUB" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="300.0" Z="1.7859402195408116">
<NAME>Central nervous system: other specific sleep-related adverse events</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Methylphenidate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methylphenidate</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.018976795270856384" CI_START="-1.318976795270857" DF="0" EFFECT_SIZE="-0.6500000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="1.0" P_Z="0.05686254839380411" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" Z="1.9043658897544058">
<NAME>Number of hours sleep</NAME>
<CONT_DATA CI_END="0.018976795270856384" CI_START="-1.318976795270857" EFFECT_SIZE="-0.6500000000000004" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="8.55" ORDER="1333" SD_1="0.65" SD_2="0.4" SE="0.34132096331752027" STUDY_ID="STD-Langevin-2012" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.219939260791705" CI_START="-57.89993926079171" DF="0" EFFECT_SIZE="-27.840000000000003" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" NO="2" P_CHI2="1.0" P_Z="0.06949013604643173" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" Z="1.815219813193927">
<NAME>Number of nocturnal movements</NAME>
<CONT_DATA CI_END="2.219939260791705" CI_START="-57.89993926079171" EFFECT_SIZE="-27.840000000000003" ESTIMABLE="YES" MEAN_1="134.24" MEAN_2="162.08" ORDER="1334" SD_1="11.525" SD_2="32.3" SE="15.336985525193663" STUDY_ID="STD-Langevin-2012" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0037158350986221E-32" CI_END="0.3429913879666191" CI_START="-0.7429913879666192" DF="0" EFFECT_SIZE="-0.20000000000000004" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-002.02.03" NO="3" P_CHI2="0.0" P_Z="0.47034768472188393" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" Z="0.7219134697070169">
<NAME>Sleep quality</NAME>
<CONT_DATA CI_END="0.34299138796661915" CI_START="-0.7429913879666192" EFFECT_SIZE="-0.2" ESTIMABLE="YES" MEAN_1="0.32" MEAN_2="0.52" ORDER="1335" SD_1="0.576" SD_2="0.228" SE="0.27704151313476466" STUDY_ID="STD-Langevin-2012" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" />
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.11929565736221975" CI_END="42.61496528930362" CI_START="0.7674142095091444" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="5.718682531908076" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="1.6295621390376798" LOG_CI_START="-0.11497016362834722" LOG_EFFECT_SIZE="0.7572959877046663" METHOD="IV" NO="3" P_CHI2="0.7297997211022231" P_Q="0.7297997211022231" P_Z="0.08882504888003218" Q="0.11929565736221975" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="430" TOTAL_2="140" WEIGHT="200.0" Z="1.701628406959894">
<NAME>Central nervous system: other specific adverse events</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="137.73501438678142" CI_START="0.47947212590564664" DF="0" EFFECT_SIZE="8.126506024096388" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="2.1390443587168435" LOG_CI_START="-0.3192366354531449" LOG_EFFECT_SIZE="0.9099038616318493" NO="1" P_CHI2="1.0" P_Z="0.14680343673709137" STUDIES="1" TAU2="0.0" TOTAL_1="165" TOTAL_2="70" WEIGHT="100.0" Z="1.4509153367103014">
<NAME>Headache</NAME>
<DICH_DATA CI_END="137.73501438678142" CI_START="0.47947212590564664" EFFECT_SIZE="8.126506024096386" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.1390443587168435" LOG_CI_START="-0.3192366354531449" LOG_EFFECT_SIZE="0.9099038616318492" ORDER="1456" O_E="0.0" SE="1.4440064246626263" STUDY_ID="STD-Tzang-2012" TOTAL_1="165" TOTAL_2="70" VAR="2.085154554466941" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="69.26549881948154" CI_START="0.2314296380485802" DF="0" EFFECT_SIZE="4.003759398496241" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="1.8405169661646736" LOG_CI_START="-0.6355810238772948" LOG_EFFECT_SIZE="0.6024679711436896" NO="2" P_CHI2="1.0" P_Z="0.3401994620498715" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="70" WEIGHT="100.0" Z="0.9537712400958201">
<NAME>Dizziness</NAME>
<DICH_DATA CI_END="69.26549881948154" CI_START="0.2314296380485802" EFFECT_SIZE="4.003759398496241" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="1.8405169661646736" LOG_CI_START="-0.6355810238772948" LOG_EFFECT_SIZE="0.6024679711436896" ORDER="1455" O_E="0.0" SE="1.4544722162333796" STUDY_ID="STD-Tzang-2012" TOTAL_1="265" TOTAL_2="70" VAR="2.1154894277948393" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.80036580612483" CI_END="5.493176508407167" CI_START="-1.59743344022106" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="1.9478715340930537" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" NO="4" P_CHI2="0.6701976836633075" P_Q="0.6701976836633075" P_Z="0.281547754751187" Q="0.8003658061248302" RANDOM="YES" SCALE="37.87" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="72" TOTAL_2="57" UNITS="" WEIGHT="300.0" Z="1.076848982243556">
<NAME>Cardiovascular and respiratory system</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.469287791186849" CI_START="-6.26928779118686" DF="0" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" NO="1" P_CHI2="1.0" P_Z="0.9754512861417529" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" Z="0.030772105905654528">
<NAME>Systolic blood pressure</NAME>
<CONT_DATA CI_END="6.469287791186849" CI_START="-6.26928779118686" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" MEAN_1="107.1" MEAN_2="107.0" ORDER="1438" SD_1="9.6" SD_2="11.3" SE="3.2496963420894383" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.123409494732805E-32" CI_END="8.42497294504706" CI_START="-1.4249729450470583" DF="0" EFFECT_SIZE="3.5000000000000004" ESTIMABLE="YES" I2="100.0" ID="CMP-002.04.02" NO="2" P_CHI2="0.0" P_Z="0.16365745506605497" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" Z="1.3928754578822653">
<NAME>Diastolic blood pressure</NAME>
<CONT_DATA CI_END="8.42497294504706" CI_START="-1.4249729450470587" EFFECT_SIZE="3.5" ESTIMABLE="YES" MEAN_1="67.7" MEAN_2="64.2" ORDER="1439" SD_1="7.9" SD_2="8.4" SE="2.5127874715528535" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.149332322630329" CI_START="-7.949332322630312" DF="0" EFFECT_SIZE="0.6000000000000085" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.03" NO="3" P_CHI2="1.0" P_Z="0.8905944349466188" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" Z="0.13755207381647824">
<NAME>Pulse rate</NAME>
<CONT_DATA CI_END="9.149332322630329" CI_START="-7.949332322630312" EFFECT_SIZE="0.6000000000000085" ESTIMABLE="YES" MEAN_1="85.4" MEAN_2="84.8" ORDER="1440" SD_1="14.7" SD_2="13.8" SE="4.3619843987268965" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" />
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.261843609418415" CI_END="7.322113740680522" CI_START="0.8918326570129953" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="2.555406064073276" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="4" I2="61.990508489835996" I2_Q="61.990508489835996" ID="CMP-002.05" LOG_CI_END="0.8646364708670439" LOG_CI_START="-0.04971662875601809" LOG_EFFECT_SIZE="0.4074599210555129" METHOD="IV" NO="5" P_CHI2="0.07201218229080364" P_Q="0.07201218229080364" P_Z="0.08066794768381566" Q="5.261843609418415" RANDOM="YES" SCALE="734.37" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.4525250811545534" TOTALS="SUB" TOTAL_1="795" TOTAL_2="210" WEIGHT="300.0" Z="1.7468235646416275">
<NAME>Gastrointestinal system</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="20.288091063701437" CI_START="0.34392452536826423" DF="0" EFFECT_SIZE="2.641509433962264" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="1.30724118554974" LOG_CI_START="-0.4635368533948421" LOG_EFFECT_SIZE="0.42185216607744896" NO="1" P_CHI2="1.0" P_Z="0.3503844798929121" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="70" WEIGHT="100.0" Z="0.9338438066521396">
<NAME>Nausea</NAME>
<DICH_DATA CI_END="20.288091063701437" CI_START="0.34392452536826423" EFFECT_SIZE="2.641509433962264" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" LOG_CI_END="1.30724118554974" LOG_CI_START="-0.4635368533948421" LOG_EFFECT_SIZE="0.42185216607744896" ORDER="864" O_E="0.0" SE="1.0401637855687083" STUDY_ID="STD-Tzang-2012" TOTAL_1="265" TOTAL_2="70" VAR="1.0819407008086255" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.8414792322294544" CI_START="0.16347387298241103" DF="0" EFFECT_SIZE="0.7924528301886793" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.5844984896515275" LOG_CI_START="-0.7865516480573046" LOG_EFFECT_SIZE="-0.10102657920288856" NO="2" P_CHI2="1.0" P_Z="0.772702262621546" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="70" WEIGHT="100.0" Z="0.2888420361487839">
<NAME>Abdominal pain</NAME>
<DICH_DATA CI_END="3.8414792322294544" CI_START="0.16347387298241103" EFFECT_SIZE="0.7924528301886793" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.5844984896515275" LOG_CI_START="-0.7865516480573046" LOG_EFFECT_SIZE="-0.10102657920288856" ORDER="869" O_E="0.0" SE="0.8053616376978059" STUDY_ID="STD-Tzang-2012" TOTAL_1="265" TOTAL_2="70" VAR="0.648607367475292" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="106.83392029532749" CI_START="2.1219975506659945" DF="0" EFFECT_SIZE="15.056603773584902" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="1" I2="0.0" ID="CMP-002.05.03" LOG_CI_END="2.028709165222427" LOG_CI_START="0.3267448782774534" LOG_EFFECT_SIZE="1.1777270217499403" NO="3" P_CHI2="1.0" P_Z="0.006677458930977184" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="70" WEIGHT="100.0" Z="2.7125158429650806">
<NAME>Decreased appetite</NAME>
<DICH_DATA CI_END="106.83392029532749" CI_START="2.1219975506659945" EFFECT_SIZE="15.056603773584905" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="1" LOG_CI_END="2.028709165222427" LOG_CI_START="0.3267448782774534" LOG_EFFECT_SIZE="1.1777270217499403" ORDER="863" O_E="0.0" SE="0.9997422470105723" STUDY_ID="STD-Tzang-2012" TOTAL_1="265" TOTAL_2="70" VAR="0.9994845604577483" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.804611972528624" CI_END="0.3700853592770556" CI_START="-1.2005584368611115" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.415236538792028" ESTIMABLE="YES" I2="55.912254628015376" I2_Q="0.0" ID="CMP-002.06" NO="6" P_CHI2="0.07839325052613377" P_Q="0.49712795474243554" P_Z="0.30005059413770985" Q="0.46106230163161244" RANDOM="YES" SCALE="5.94" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.24498218774197472" TOTALS="SUB" TOTAL_1="144" TOTAL_2="42" UNITS="" WEIGHT="200.0" Z="1.036324930068168">
<NAME>Musculoskeletal system</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methylphenidate</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.596140552059303" CI_END="0.7510852292230864" CI_START="-2.611681801269386" DF="1" EFFECT_SIZE="-0.9302982860231498" ESTIMABLE="YES" I2="78.24261489235899" ID="CMP-002.06.01" NO="1" P_CHI2="0.03204407642145635" P_Z="0.27817198818560285" STUDIES="2" TAU2="1.1798654543289295" TOTAL_1="72" TOTAL_2="21" WEIGHT="100.0" Z="1.0844350018607674">
<NAME>Height</NAME>
<CONT_DATA CI_END="0.4071194981876619" CI_START="-0.7997575349974783" EFFECT_SIZE="-0.19631901840490815" ESTIMABLE="YES" MEAN_1="1.35" MEAN_2="1.37" ORDER="2660" SD_1="0.1" SD_2="0.1" SE="0.3078824515921803" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="57.73564648044636" />
<CONT_DATA CI_END="-0.46443266640328473" CI_START="-3.4014834711997466" EFFECT_SIZE="-1.9329580688015155" ESTIMABLE="YES" MEAN_1="-1.86" MEAN_2="-0.26" ORDER="2663" SD_1="0.82" SD_2="0.51" SE="0.7492614221392698" STUDY_ID="STD-Zhang-2010" TOTAL_1="48" TOTAL_2="2" WEIGHT="42.264353519553644" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.6147546217029287" CI_END="0.6166288279670677" CI_START="-1.1596735925049158" DF="1" EFFECT_SIZE="-0.27152238226892395" ESTIMABLE="YES" I2="38.07108606102674" ID="CMP-002.06.02" NO="2" P_CHI2="0.20382479045298008" P_Z="0.5490441166586633" STUDIES="2" TAU2="0.19235916568645453" TOTAL_1="72" TOTAL_2="21" WEIGHT="100.0" Z="0.5991931149901866">
<NAME>Weight</NAME>
<CONT_DATA CI_END="0.6155142086681937" CI_START="-0.5882332346319217" EFFECT_SIZE="0.013640487018136083" ESTIMABLE="YES" MEAN_1="34.1" MEAN_2="34.0" ORDER="2661" SD_1="6.3" SD_2="8.2" SE="0.30708407215518285" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="71.63262376191894" />
<CONT_DATA CI_END="0.4372940250341798" CI_START="-2.4205117794932867" EFFECT_SIZE="-0.9916088772295534" ESTIMABLE="YES" MEAN_1="-2.16" MEAN_2="-1.22" ORDER="2664" SD_1="0.94" SD_2="0.51" SE="0.7290454893736502" STUDY_ID="STD-Zhang-2010" TOTAL_1="48" TOTAL_2="2" WEIGHT="28.367376238081064" />
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.24197304739369496" CI_START="-2.958026952606308" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.020933035476232476" Q="0.0" RANDOM="YES" SCALE="7.24" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="19" UNITS="" WEIGHT="100.0" Z="2.309190085841546">
<NAME>Musculoskeletal system: body mass index (BMI)</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methylphenidate</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.24197304739369518" CI_START="-2.958026952606308" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="16.7" MEAN_2="18.3" ORDER="2662" SD_1="2.2" SD_2="2.3" SE="0.6928836260861166" STUDY_ID="STD-Verret-2010" TOTAL_1="24" TOTAL_2="19" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.417766922133367" CI_END="0.0543270759214997" CI_START="-0.21347707123693654" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07957499765771843" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" NO="8" P_CHI2="0.49219350987526955" P_Q="0.49219350987526955" P_Z="0.24411511543686426" Q="1.417766922133367" RANDOM="YES" SCALE="1.26" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="405" TOTAL_2="420" UNITS="" WEIGHT="300.0" Z="1.1647626157687319">
<NAME>Musculoskeletal system: z scores</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methylphenidate</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.04993124916787958" CI_START="-0.4299312491678796" DF="0" EFFECT_SIZE="-0.19" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" NO="1" P_CHI2="1.0" P_Z="0.1206424208685118" STUDIES="1" TAU2="0.0" TOTAL_1="135" TOTAL_2="140" WEIGHT="100.0" Z="1.552082766851463">
<NAME>Height z score</NAME>
<CONT_DATA CI_END="0.04993124916787958" CI_START="-0.4299312491678796" EFFECT_SIZE="-0.19" ESTIMABLE="YES" MEAN_1="-0.23" MEAN_2="-0.04" ORDER="63" SD_1="0.99" SD_2="1.04" SE="0.12241615206219433" STUDY_ID="STD-Dubnov_x002d_Raz-2011" TOTAL_1="135" TOTAL_2="140" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.159289814953957" CI_START="-0.299289814953957" DF="0" EFFECT_SIZE="-0.07" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" NO="2" P_CHI2="1.0" P_Z="0.549600843103024" STUDIES="1" TAU2="0.0" TOTAL_1="135" TOTAL_2="140" WEIGHT="100.0" Z="0.5983583655704638">
<NAME>Weight z score</NAME>
<CONT_DATA CI_END="0.159289814953957" CI_START="-0.299289814953957" EFFECT_SIZE="-0.07" ESTIMABLE="YES" MEAN_1="0.07" MEAN_2="0.14" ORDER="64" SD_1="0.95" SD_2="0.99" SE="0.1169867491252726" STUDY_ID="STD-Dubnov_x002d_Raz-2011" TOTAL_1="135" TOTAL_2="140" WEIGHT="100.0" />
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.23714814496323186" CI_START="-0.21714814496323184" DF="0" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.03" NO="3" P_CHI2="1.0" P_Z="0.9312392947921243" STUDIES="1" TAU2="0.0" TOTAL_1="135" TOTAL_2="140" WEIGHT="99.99999999999999" Z="0.0862857138832154">
<NAME>BMI z score</NAME>
<CONT_DATA CI_END="0.23714814496323186" CI_START="-0.21714814496323184" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.23" MEAN_2="0.22" ORDER="65" SD_1="0.9" SD_2="1.02" SE="0.11589404027571293" STUDY_ID="STD-Dubnov_x002d_Raz-2011" TOTAL_1="135" TOTAL_2="140" WEIGHT="99.99999999999999" />
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Comparative studies: number of participants withdrawn from methylphenidate treatment</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="98" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="7.02" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="146" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Proportion of participants withdrawn from methylphenidate for unknown reasons</NAME>
<GROUP_LABEL_1>Methylphenidate</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours methylphenidate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8381844170707853" CI_START="0.6201194095100248" EFFECT_SIZE="0.7209538305428717" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="27" LOG_CI_END="-0.0766604175215952" LOG_CI_START="-0.2075246751823517" LOG_EFFECT_SIZE="-0.14209254635197346" ORDER="1514" O_E="0.0" SE="0.07687031273845117" STUDY_ID="STD-Zhang-2010" TOTAL_1="146" TOTAL_2="29" VAR="0.005909044980507289" WEIGHT="0.0" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Non-comparative studies: proportion of participants with serious adverse events</NAME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="50" SUBGROUPS="NO">
<NAME>Any serious adverse event</NAME>
<TR>
<TH>
<P>Symptoms</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="40" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>No patients experienced any serious adverse events</P>
</TD>
<TD>
<P>0/221</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="41" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>Severe anorexia</P>
</TD>
<TD>
<P>1/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="42" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="43" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>3/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="44" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Acute depression and suicide attempt</P>
</TD>
<TD>
<P>1/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="45" STUDY_ID="STD-Ashkenasi-2011">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="46" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>4/822</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="47" STUDY_ID="STD-Cherland-1999">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>13/98</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="48" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="49" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>64/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="50" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="51" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/247</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="52" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>21/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="53" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>38/822</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="54" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>3/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="55" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>7/1098</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="56" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>2/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="57" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>3/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="58" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Participants affected or at risk</P>
</TD>
<TD>
<P>5/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="59" STUDY_ID="STD-Hammerness-2012">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="60" STUDY_ID="STD-Hulvershorn-2012">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="61" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="62" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>1/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="63" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Sudden death</P>
</TD>
<TD>
<P>0/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="64" STUDY_ID="STD-Kim-2011">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/97</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="65" STUDY_ID="STD-Lakic-2012">
<TR>
<TD>
<P>Strong depressive symptoms</P>
</TD>
<TD>
<P>1/68</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="66" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>542/4055</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="67" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/36</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="68" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="69" STUDY_ID="STD-McCarthy-2009">
<TR>
<TD>
<P>Sudden death</P>
</TD>
<TD>
<P>5/5351</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="70" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="71" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>3/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="72" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="73" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>4/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="74" STUDY_ID="STD-Schmidt-2002">
<TR>
<TD>
<P>Generalized tonic-clonic seizure</P>
</TD>
<TD>
<P>1/124</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="75" STUDY_ID="STD-Schulz-2010">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/145</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="76" STUDY_ID="STD-Shin-2016">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>1224/123,636</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="77" STUDY_ID="STD-Sobanski-2013">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>8/347</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="78" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/73</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="79" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="80" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="81" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="82" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="83" STUDY_ID="STD-Wigal-2011">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="84" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="85" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>1/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="86" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>1/87</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="87" STUDY_ID="STD-Wilens-2008">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="88" STUDY_ID="STD-Winterstein-2009">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>171/18,238</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="89" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>Serious adverse events</P>
</TD>
<TD>
<P>0/149</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="YES">
<NAME>Central nervous system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-004.02.01" NO="1" STUDIES="3">
<NAME>Sudden death</NAME>
<OTHER_DATA ORDER="90" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Sudden death</P>
</TD>
<TD>
<P>0/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="91" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Sudden death</P>
</TD>
<TD>
<P>7/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="92" STUDY_ID="STD-McCarthy-2009">
<TR>
<TD>
<P>Sudden death</P>
</TD>
<TD>
<P>1/5351</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.02" NO="2" STUDIES="2">
<NAME>Suicide</NAME>
<OTHER_DATA ORDER="93" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Suicide </P>
</TD>
<TD>
<P>1/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="94" STUDY_ID="STD-McCarthy-2009">
<TR>
<TD>
<P>Suicide</P>
</TD>
<TD>
<P>4/5351</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.03" NO="3" STUDIES="3">
<NAME>Suicide attempt</NAME>
<OTHER_DATA ORDER="95" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Acute depression and suicide attempt</P>
</TD>
<TD>
<P>1/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="96" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Suicide attempt</P>
</TD>
<TD>
<P>6/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="97" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Suicide attempt</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.04" NO="4" STUDIES="2">
<NAME>Suicide thoughts</NAME>
<OTHER_DATA ORDER="98" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Depressive, suicidal thoughts</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="99" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Serious adverse events were reported in only 1 participant during the open-label, dose-titration phase of the study</P>
</TD>
<TD>
<P>1/87</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.05" NO="5" STUDIES="10">
<NAME>Psychotic symptoms</NAME>
<OTHER_DATA ORDER="100" STUDY_ID="STD-Cherland-1999">
<TR>
<TD>
<P>Psychotic symptoms</P>
</TD>
<TD>
<P>7/96</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="101" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>2/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="102" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Paranoid behavior disorder</P>
</TD>
<TD>
<P>3/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="103" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>0/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="104" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="105" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>0/55</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="106" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Delusions</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="107" STUDY_ID="STD-Shyu-2015">
<TR>
<TD>
<P>Psychotic disorders</P>
</TD>
<TD>
<P>856/52,646</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="108" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="109" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Hallucinations</P>
</TD>
<TD>
<P>0/369</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.06" NO="6" STUDIES="2">
<NAME>Seizure</NAME>
<OTHER_DATA ORDER="110" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Seizures</P>
</TD>
<TD>
<P>3/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="111" STUDY_ID="STD-Schmidt-2002">
<TR>
<TD>
<P>Generalized tonic-clonic seizure</P>
</TD>
<TD>
<P>1/124</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.07" NO="7" STUDIES="2">
<NAME>Syncope</NAME>
<OTHER_DATA ORDER="112" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Syncope</P>
</TD>
<TD>
<P>1/327</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="113" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Vasovagal syncope</P>
</TD>
<TD>
<P>1/1098</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.08" NO="8" STUDIES="2">
<NAME>Tremor</NAME>
<OTHER_DATA ORDER="114" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Tremor</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="115" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Tremor</P>
</TD>
<TD>
<P>1/306</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.09" NO="9" STUDIES="3">
<NAME>Psychiatric problems</NAME>
<OTHER_DATA ORDER="116" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Rambling speech</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="117" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Psychiatric disorder</P>
</TD>
<TD>
<P>5/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="118" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Psychiatric problems</P>
</TD>
<TD>
<P>5/1098</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.10" NO="10" STUDIES="2">
<NAME>Severe depression</NAME>
<OTHER_DATA ORDER="119" STUDY_ID="STD-Cherland-1999">
<TR>
<TD>
<P>Severe depression</P>
</TD>
<TD>
<P>1/98</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="120" STUDY_ID="STD-Lakic-2012">
<TR>
<TD>
<P>Strong depressive symptoms</P>
</TD>
<TD>
<P>1/68</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.11" NO="11" STUDIES="1">
<NAME>Overdose</NAME>
<OTHER_DATA ORDER="121" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Overdose</P>
</TD>
<TD>
<P>6/100</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.12" NO="12" STUDIES="1">
<NAME>Eating disorder</NAME>
<OTHER_DATA ORDER="122" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Eating disorder</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.13" NO="13" STUDIES="1">
<NAME>Aphasia</NAME>
<OTHER_DATA ORDER="123" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Aphasia</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.14" NO="14" STUDIES="1">
<NAME>Headache</NAME>
<OTHER_DATA ORDER="124" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.15" NO="15" STUDIES="1">
<NAME>Neurological disorder</NAME>
<OTHER_DATA ORDER="125" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Neurologicaol disorder</P>
</TD>
<TD>
<P>2/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.16" NO="16" STUDIES="1">
<NAME>Sleep disorder</NAME>
<OTHER_DATA ORDER="126" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.17" NO="17" STUDIES="1">
<NAME>Mood disorder</NAME>
<OTHER_DATA ORDER="127" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Mood disorder</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.18" NO="18" STUDIES="1">
<NAME>Loss of consciousness</NAME>
<OTHER_DATA ORDER="128" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Short loss of consciousness</P>
</TD>
<TD>
<P>1/306</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.19" NO="19" STUDIES="1">
<NAME>Family stress</NAME>
<OTHER_DATA ORDER="129" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Family stress</P>
</TD>
<TD>
<P>1/306</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.20" NO="20" STUDIES="1">
<NAME>Impotence</NAME>
<OTHER_DATA ORDER="130" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Impotence</P>
</TD>
<TD>
<P>1/1098</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.21" NO="21" STUDIES="1">
<NAME>Severe aggression</NAME>
<OTHER_DATA ORDER="131" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Severe aggression</P>
</TD>
<TD>
<P>1/89</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.22" NO="22" STUDIES="1">
<NAME>Severe anorexia</NAME>
<OTHER_DATA ORDER="132" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>Severe anorexia</P>
</TD>
<TD>
<P>1/18</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.02.23" NO="23" STUDIES="1">
<NAME>Amphetamine intoxication</NAME>
<OTHER_DATA ORDER="133" STUDY_ID="STD-Cherland-1999">
<TR>
<TD>
<P>Amphetamine intoxication</P>
</TD>
<TD>
<P>3/98</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Cardiovascular and respiratory system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-004.03.01" NO="1" STUDIES="2">
<NAME>Respiratory, thoracic and mediastinal disorders</NAME>
<OTHER_DATA ORDER="134" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Aortic embolism</P>
</TD>
<TD>
<P>1/1098</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="135" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Spontaneous pneumothorax</P>
</TD>
<TD>
<P>1/57</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.03.02" NO="2" STUDIES="3">
<NAME>Cardiac problems</NAME>
<OTHER_DATA ORDER="136" STUDY_ID="STD-Arman-2013">
<TR>
<TD>
<P>Cardiac rhythm abnormalities</P>
</TD>
<TD>
<P>0/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="137" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Cardiovascular problems</P>
</TD>
<TD>
<P>2/1098</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="138" STUDY_ID="STD-Winterstein-2009">
<TR>
<TD>
<P>Serious cardiac problems</P>
</TD>
<TD>
<P>171/18,238</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.03.03" NO="3" STUDIES="2">
<NAME>Tachycardia</NAME>
<OTHER_DATA ORDER="139" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>2/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="140" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>2/1098</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.03.04" NO="4" STUDIES="1">
<NAME>Severe hypertension</NAME>
<OTHER_DATA ORDER="141" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Severe hypertension</P>
</TD>
<TD>
<P>2/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.03.05" NO="5" STUDIES="1">
<NAME>Epistaxsis</NAME>
<OTHER_DATA ORDER="142" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Epistaxsis</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.03.06" NO="6" STUDIES="1">
<NAME>Viral illness</NAME>
<OTHER_DATA ORDER="143" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Participants affected by viral illness</P>
</TD>
<TD>
<P>1/57</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.04" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Gastrointestinal system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-004.04.01" NO="1" STUDIES="1">
<NAME>Gastrointestinal disease</NAME>
<OTHER_DATA ORDER="144" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Gastrointestinal disease</P>
</TD>
<TD>
<P>6/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.04.02" NO="2" STUDIES="1">
<NAME>Liver disease</NAME>
<OTHER_DATA ORDER="145" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Hyperbilrubinemia</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.05" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO">
<NAME>Musculoskeletal system: fractures</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="146" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Ankle fracture</P>
</TD>
<TD>
<P>1/327</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="147" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Leg fracture</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-004.06" NO="6" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Immune system: autoimmune disease</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="148" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Autoimmune disease</P>
</TD>
<TD>
<P>1/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Non-comparative studies: proportion of participants withdrawn from methylphenidate treatment due to serious adverse events</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-005.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES">
<NAME>Proportion of participants withdrawn from methylphenidate treatment due to serious adverse events</NAME>
<TR>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-005.01.01" NO="1" STUDIES="7">
<NAME>Serious adverse events</NAME>
<OTHER_DATA ORDER="149" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>1/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="150" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>1/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="151" STUDY_ID="STD-Ashkenasi-2011">
<TR>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="152" STUDY_ID="STD-Faraone-2007a">
<TR>
<TD>
<P>3/268</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="153" STUDY_ID="STD-Findling-2010">
<TR>
<TD>
<P>2/162</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="154" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>1/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="155" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>1/407</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.01.02" NO="2" STUDIES="3">
<NAME>Hallucinations</NAME>
<OTHER_DATA ORDER="156" STUDY_ID="STD-Ashkenasi-2011">
<TR>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="157" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>1/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="158" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>1/407</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.01.03" NO="3" STUDIES="1">
<NAME>Severe anorexia</NAME>
<OTHER_DATA ORDER="159" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>1/18</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.01.04" NO="4" STUDIES="1">
<NAME>Suicide attempt</NAME>
<OTHER_DATA ORDER="160" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>1/171</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-005.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="NO">
<NAME>Proportion of participants withdrawn from methylphenidate treatment due to adverse events of unknown severity</NAME>
<TR>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="161" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>4/204</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="162" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>4/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="163" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>4/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="164" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>17/189</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="165" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>15/296</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="166" STUDY_ID="STD-Dodangi-2011">
<TR>
<TD>
<P>2/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="167" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>26/822</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="168" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>51/326</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="169" STUDY_ID="STD-Kim-2015b">
<TR>
<TD>
<P>8/143</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="170" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>53/598</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="171" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>5/44</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="172" STUDY_ID="STD-Lee-2009">
<TR>
<TD>
<P>28/144</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="173" STUDY_ID="STD-Lee-2012">
<TR>
<TD>
<P>1/93</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="174" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>3/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="175" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>2/69</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="176" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>1/69</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="177" STUDY_ID="STD-Mohammadi-2009">
<TR>
<TD>
<P>6/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="178" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>16/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="179" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>6/73</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="180" STUDY_ID="STD-Yang-2004">
<TR>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="181" STUDY_ID="STD-Yang-2012">
<TR>
<TD>
<P>15/130</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="182" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>3/50</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Non-comparative studies: proportion of participants with adverse events of unknown severity</NAME>
<OTHER_OUTCOME COLS="2" ID="CMP-006.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Proportion of participants with adverse events of unknown severity</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="183" STUDY_ID="STD-Barbaresi-2006">
<TR>
<TD>
<P>Adverse events of unknown seriousness</P>
</TD>
<TD>
<P>63/251</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Non-comparative studies: proportion of participants with non-serious adverse events</NAME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="49" SUBGROUPS="NO">
<NAME>Non-serious adverse events</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="184" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>21/142</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="185" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Any adverse event (with OROS (osmotic controlled release oral delivery system) methylphenidate)</P>
</TD>
<TD>
<P>52/122</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="186" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Any adverse event</P>
</TD>
<TD>
<P>76/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="187" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Total number of patients who experience adverse events</P>
</TD>
<TD>
<P>54/134</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="188" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>5/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="189" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>195/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="190" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>95/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="191" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>369/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="192" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>78/287</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="193" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>25/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="194" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>209/822</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="195" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>40/106</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="196" STUDY_ID="STD-Findling-2010">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>68/88</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="197" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>18/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="198" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>180/607</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="199" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>160/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="200" STUDY_ID="STD-Goez-2012">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>7/28</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="201" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>14/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="202" STUDY_ID="STD-Greenberg-1987">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>8/49</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="203" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>5/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="204" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>26/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="205" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>27/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="206" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>45/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="207" STUDY_ID="STD-Hammerness-2012">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>0/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="208" STUDY_ID="STD-Haubold-2010">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>32/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="209" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>150/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="210" STUDY_ID="STD-Karabekiroglu-2008">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>28/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="211" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>At least one adverse drug reaction</P>
</TD>
<TD>
<P>71/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="212" STUDY_ID="STD-Kim-2015b">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>8/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="213" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>172/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="214" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>3513/4055</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="215" STUDY_ID="STD-Lyon-2010">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>7/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="216" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>35/63</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="217" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>58/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="218" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Total number of patients who experienced adverse events</P>
</TD>
<TD>
<P>98/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="219" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>76/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="220" STUDY_ID="STD-Schulz-2010">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>36/145</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="221" STUDY_ID="STD-Sobanski-2013">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>26/347</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="222" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>116/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="223" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>101/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="224" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>12/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="225" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>177/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="226" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>242/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="227" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>64/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="228" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>42/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="229" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>344/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="230" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>96/135</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="231" STUDY_ID="STD-Yatsuga-2014">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>7/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="232" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>Total adverse events</P>
</TD>
<TD>
<P>24/123</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="110" SUBGROUPS="YES">
<NAME>Central nervous system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.02.01" NO="1" STUDIES="2">
<NAME>Affect lability</NAME>
<OTHER_DATA ORDER="233" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Moodiness</P>
</TD>
<TD>
<P>10/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="234" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Affect lability</P>
</TD>
<TD>
<P>12/44</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.02" NO="2" STUDIES="14">
<NAME>Aggression</NAME>
<OTHER_DATA ORDER="235" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Anger</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="236" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Aggressive reaction</P>
</TD>
<TD>
<P>13/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="237" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>1/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="238" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>0/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="239" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>31/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="240" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>2/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="241" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>3/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="242" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>10/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="243" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>10/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="244" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>7/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="245" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>1/69</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="246" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Anger</P>
</TD>
<TD>
<P>6/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="247" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Aggression</P>
</TD>
<TD>
<P>1/105</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="248" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Hostility</P>
</TD>
<TD>
<P>8/407</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.03" NO="3" STUDIES="23">
<NAME>Anorexia</NAME>
<OTHER_DATA ORDER="249" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>8/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="250" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>16/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="251" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>6/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="252" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>35/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="253" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>9/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="254" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>9/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="255" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>0/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="256" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>20/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="257" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>5/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="258" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>11/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="259" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>45/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="260" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>23/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="261" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>6/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="262" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>29/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="263" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>66/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="264" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>104/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="265" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>42/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="266" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>9/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="267" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>16/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="268" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>22/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="269" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>9/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="270" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>36/128</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="271" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>12/61</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.04" NO="4" STUDIES="22">
<NAME>Anxiety</NAME>
<OTHER_DATA ORDER="272" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="273" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>3/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="274" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="275" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Anxiety, nervousness</P>
</TD>
<TD>
<P>4/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="276" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="277" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Anxiety or nervousness</P>
</TD>
<TD>
<P>12/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="278" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Phobia &amp; anxiety</P>
</TD>
<TD>
<P>2/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="279" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Anxiousness</P>
</TD>
<TD>
<P>76/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="280" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Anxious</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="281" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Anxious</P>
</TD>
<TD>
<P>10/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="282" STUDY_ID="STD-Ghanizadeh-2012">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>1/12</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="283" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Anxiousness</P>
</TD>
<TD>
<P>4/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="284" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="285" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Anxious</P>
</TD>
<TD>
<P>6/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="286" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="287" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Anxious</P>
</TD>
<TD>
<P>12/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="288" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="289" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>9/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="290" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>9/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="291" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>12/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="292" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>9/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="293" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Anxiety</P>
</TD>
<TD>
<P>21/128</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.05" NO="5" STUDIES="9">
<NAME>Fingernail biting</NAME>
<OTHER_DATA ORDER="294" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Bites fingernails</P>
</TD>
<TD>
<P>9/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="295" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Biting fingernails</P>
</TD>
<TD>
<P>56/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="296" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Bites fingers</P>
</TD>
<TD>
<P>0/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="297" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Biting fingernails</P>
</TD>
<TD>
<P>8/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="298" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Biting fingernails</P>
</TD>
<TD>
<P>3/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="299" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Biting fingernails</P>
</TD>
<TD>
<P>2/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="300" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Bites fingernails</P>
</TD>
<TD>
<P>3/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="301" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Nail biting</P>
</TD>
<TD>
<P>3/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="302" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Nail biting</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.06" NO="6" STUDIES="4">
<NAME>Daydreams</NAME>
<OTHER_DATA ORDER="303" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Daydreams</P>
</TD>
<TD>
<P>77/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="304" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Daydreams</P>
</TD>
<TD>
<P>10/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="305" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Daydreams</P>
</TD>
<TD>
<P>3/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="306" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Daydreams</P>
</TD>
<TD>
<P>7/30</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.07" NO="7" STUDIES="82">
<NAME>Difficulty falling asleep</NAME>
<OTHER_DATA ORDER="307" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>4/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="308" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>6/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="309" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>5/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="310" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>8/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="311" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>19/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="312" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>16/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="313" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="314" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>3/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="315" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="316" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>59/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="317" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Insomnia </P>
</TD>
<TD>
<P>21/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="318" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>25/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="319" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>31/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="320" STUDY_ID="STD-Co_x015f_kun-2010">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>4/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="321" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>7/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="322" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Initial insomnia</P>
</TD>
<TD>
<P>11/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="323" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Initial insomnia</P>
</TD>
<TD>
<P>3/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="324" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>79/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="325" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="326" STUDY_ID="STD-Famularo-1987">
<TR>
<TD>
<P>Later sleep onset</P>
</TD>
<TD>
<P>1/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="327" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="328" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Insomnia or trouble sleeping</P>
</TD>
<TD>
<P>15/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="329" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>1/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="330" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>73/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="331" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>7/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="332" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>7/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="333" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>2/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="334" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>19/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="335" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>3/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="336" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>7/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="337" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="338" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>10/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="339" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>12/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="340" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Insomnia (new onset)</P>
</TD>
<TD>
<P>12/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="341" STUDY_ID="STD-Jung-2007">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>16/83</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="342" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>53/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="343" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>44/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="344" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>6/24</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="345" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>46/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="346" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>7/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="347" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>24110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="348" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>9/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="349" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>3/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="350" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>5/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="351" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/63</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="352" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>20/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="353" STUDY_ID="STD-Miller_x002d_Horn-2008">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>2/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="354" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>4/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="355" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>9/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="356" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>8/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="357" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="358" STUDY_ID="STD-Monta_x00f1__x00e9_s_x002d_Rada-2012">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>5/40</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="359" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>37/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="360" STUDY_ID="STD-Peyre-2012a">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>21/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="361" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>3/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="362" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>16/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="363" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>21/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="364" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>12/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="365" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>44/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="366" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>12/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="367" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>20/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="368" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>1/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="369" STUDY_ID="STD-Thorell-2009">
<TR>
<TD>
<P>Difficulties falling asleep</P>
</TD>
<TD>
<P>15/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="370" STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>45/114</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="371" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Initial insomnia</P>
</TD>
<TD>
<P>11/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="372" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="373" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Difficulty falling asleep</P>
</TD>
<TD>
<P>25/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="374" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>13/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="375" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="376" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>24/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="377" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>81/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="378" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>16/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="379" STUDY_ID="STD-Wilens-2008">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>25/127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="380" STUDY_ID="STD-Yatsuga-2014">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>4/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="381" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Difficulty sleeping</P>
</TD>
<TD>
<P>15/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="382" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>7/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="383" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>10/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="384" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>31/128</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="385" STUDY_ID="STD-Zeni-2007">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>21/106</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="386" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>145/1154</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="387" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>3/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="388" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>5/61</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.08" NO="8" STUDIES="13">
<NAME>Depression</NAME>
<OTHER_DATA ORDER="389" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Vegetative symptoms</P>
</TD>
<TD>
<P>4/134</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="390" STUDY_ID="STD-Cherland-1999">
<TR>
<TD>
<P>Mood symptoms or mood-congruent psychotic symptoms</P>
</TD>
<TD>
<P>11/98</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="391" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Depressed mood</P>
</TD>
<TD>
<P>13/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="392" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>1/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="393" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>1/262</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="394" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="395" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>9/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="396" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>5/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="397" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Depressive symptoms</P>
</TD>
<TD>
<P>7/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="398" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>5/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="399" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>6/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="400" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Depressive symptoms</P>
</TD>
<TD>
<P>4/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="401" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.09" NO="9" STUDIES="24">
<NAME>Disturbed sleep</NAME>
<OTHER_DATA ORDER="402" STUDY_ID="STD-Abbas-2006">
<TR>
<TD>
<P>Sleeping problems</P>
</TD>
<TD>
<P>4/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="403" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>10/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="404" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>Disturbed sleep</P>
</TD>
<TD>
<P>4/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="405" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>9/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="406" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Early waking</P>
</TD>
<TD>
<P>6/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="407" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Trouble sleeping</P>
</TD>
<TD>
<P>79/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="408" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>29/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="409" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Restless sleep</P>
</TD>
<TD>
<P>14/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="410" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>Poor sleep quality</P>
</TD>
<TD>
<P>37/607</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="411" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="412" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>7/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="413" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>8/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="414" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Sleep problems</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="415" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>6/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="416" STUDY_ID="STD-Kim-2011">
<TR>
<TD>
<P>Poor sleep</P>
</TD>
<TD>
<P>8/97</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="417" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Disturbed sleep</P>
</TD>
<TD>
<P>4/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="418" STUDY_ID="STD-Monta_x00f1__x00e9_s_x002d_Rada-2012">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>5/40</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="419" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Poor sleep</P>
</TD>
<TD>
<P>13/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="420" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Delayed sleep</P>
</TD>
<TD>
<P>1/105</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="421" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>3/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="422" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Poor quality sleep</P>
</TD>
<TD>
<P>1/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="423" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>33/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="424" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Insomnia</P>
</TD>
<TD>
<P>7/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="425" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>Poor sleep quality</P>
</TD>
<TD>
<P>3/149</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.10" NO="10" STUDIES="29">
<NAME>Dizziness</NAME>
<OTHER_DATA ORDER="426" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>8/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="427" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Dizzy</P>
</TD>
<TD>
<P>1/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="428" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>9/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="429" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>5/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="430" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="431" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>1/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="432" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>15/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="433" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>0/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="434" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>3/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="435" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="436" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>4/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="437" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>7/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="438" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>1/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="439" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>7/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="440" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="441" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>5/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="442" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>4/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="443" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>3/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="444" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>6/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="445" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>2/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="446" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>2/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="447" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>11/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="448" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="449" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>6/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="450" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="451" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>15/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="452" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>12/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="453" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>7/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="454" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Dizziness</P>
</TD>
<TD>
<P>2/47</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.11" NO="11" STUDIES="17">
<NAME>Drowsiness</NAME>
<OTHER_DATA ORDER="455" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="456" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>22/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="457" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="458" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="459" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>6/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="460" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>1/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="461" STUDY_ID="STD-Ghanizadeh-2012">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>2/12</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="462" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>2/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="463" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>7/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="464" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Somnolens</P>
</TD>
<TD>
<P>0/40</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="465" STUDY_ID="STD-Lyon-2010">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>2/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="466" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>1/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="467" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Drowsiness</P>
</TD>
<TD>
<P>8/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="468" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>6/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="469" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>10/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="470" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>3/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="471" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>1/11</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.12" NO="12" STUDIES="2">
<NAME>Dysthymia</NAME>
<OTHER_DATA ORDER="472" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Dysphemia</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="473" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Dysphemia</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.13" NO="13" STUDIES="16">
<NAME>Emotional lability</NAME>
<OTHER_DATA ORDER="474" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Emotional change</P>
</TD>
<TD>
<P>22/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="475" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="476" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>5/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="477" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Moody</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="478" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Emotional disturbance</P>
</TD>
<TD>
<P>5/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="479" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>8/598</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="480" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="481" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>2/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="482" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Affect lability</P>
</TD>
<TD>
<P>14/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="483" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>4/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="484" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>9/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="485" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Affect lability</P>
</TD>
<TD>
<P>18/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="486" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>3/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="487" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Affect lability</P>
</TD>
<TD>
<P>10/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="488" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>1/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="489" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Emotional lability</P>
</TD>
<TD>
<P>12/47</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.14" NO="14" STUDIES="9">
<NAME>Euphoria/hypomania</NAME>
<OTHER_DATA ORDER="490" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Unusually happy</P>
</TD>
<TD>
<P>12/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="491" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Euphoria</P>
</TD>
<TD>
<P>0/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="492" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Euphoric</P>
</TD>
<TD>
<P>3/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="493" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>2/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="494" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Unusually happy</P>
</TD>
<TD>
<P>0/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="495" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Euphoria</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="496" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Euphoric</P>
</TD>
<TD>
<P>2/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="497" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Euphoria or hypomania</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="498" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Ecstasy</P>
</TD>
<TD>
<P>8/30</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.15" NO="15" STUDIES="19">
<NAME>Asthenia and fatigue</NAME>
<OTHER_DATA ORDER="499" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>13/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="500" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Asthenia</P>
</TD>
<TD>
<P>7/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="501" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Tired + low energy</P>
</TD>
<TD>
<P>4/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="502" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Tiredness</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="503" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>0/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="504" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>0/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="505" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Daytime sleepiness</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="506" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="507" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Asthenia</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="508" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>3/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="509" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>5/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="510" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>5/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="511" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>4/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="512" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>13/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="513" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="514" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>3/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="515" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>7/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="516" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>5/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="517" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Fatigue</P>
</TD>
<TD>
<P>10/200</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.16" NO="16" STUDIES="90">
<NAME>Headache</NAME>
<OTHER_DATA ORDER="518" STUDY_ID="STD-Abbas-2006">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="519" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>12/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="520" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>6/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="521" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="522" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="523" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="524" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>16/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="525" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>24/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="526" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>12/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="527" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>6/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="528" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="529" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>15/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="530" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="531" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="532" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>62/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="533" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>17/287</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="534" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="535" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>9/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="536" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>8/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="537" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>30/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="538" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="539" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>54/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="540" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Morning headache</P>
</TD>
<TD>
<P>3/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="541" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="542" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>11/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="543" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>21/607</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="544" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>15/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="545" STUDY_ID="STD-Goez-2012">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/28</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="546" STUDY_ID="STD-Golubchik-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="547" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>8/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="548" STUDY_ID="STD-Greenberg-1987">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/49</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="549" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="550" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="551" STUDY_ID="STD-Guerreiro-1996">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="552" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="553" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="554" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>8/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="555" STUDY_ID="STD-Hulvershorn-2012">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="556" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="557" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>10/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="558" STUDY_ID="STD-Jung-2007">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>8/83</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="559" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>33/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="560" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="561" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="562" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="563" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>13/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="564" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>16/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="565" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>6/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="566" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="567" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="568" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Headaches</P>
</TD>
<TD>
<P>4/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="569" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/63</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="570" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>23/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="571" STUDY_ID="STD-Miller_x002d_Horn-2008">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="572" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="573" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>15/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="574" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="575" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="576" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>32/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="577" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>13/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="578" STUDY_ID="STD-Peyre-2012a">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>43/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="579" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>6/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="580" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/105</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="581" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="582" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>12/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="583" STUDY_ID="STD-Schulz-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>9/145</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="584" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="585" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="586" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>30/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="587" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>14/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="588" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>4/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="589" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>1/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="590" STUDY_ID="STD-Thorell-2009">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>6/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="591" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="592" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>11/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="593" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>16/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="594" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>23/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="595" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>10/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="596" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="597" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>35/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="598" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>123/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="599" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>25/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="600" STUDY_ID="STD-Wilens-2008">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>27/127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="601" STUDY_ID="STD-Yatsuga-2014">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>7/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="602" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>27/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="603" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="604" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>11/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="605" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>107/128</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="606" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>143/1154</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="607" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Headache</P>
</TD>
<TD>
<P>2/61</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.17" NO="17" STUDIES="8">
<NAME>Increased need to sleep</NAME>
<OTHER_DATA ORDER="608" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Trouble waking</P>
</TD>
<TD>
<P>1/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="609" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Hard to wake + difficult to wake</P>
</TD>
<TD>
<P>14/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="610" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Increased need to sleep</P>
</TD>
<TD>
<P>5/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="611" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Sleepiness</P>
</TD>
<TD>
<P>4/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="612" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>8/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="613" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="614" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>6/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="615" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>3/19</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.18" NO="18" STUDIES="7">
<NAME>Involuntary movements</NAME>
<OTHER_DATA ORDER="616" STUDY_ID="STD-Bal_x00e1_zs-2011">
<TR>
<TD>
<P>Involuntary movements after methylphenidate treatment</P>
</TD>
<TD>
<P>9/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="617" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Muscle contractions, involuntary</P>
</TD>
<TD>
<P>34/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="618" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Shaking + tremor</P>
</TD>
<TD>
<P>4/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="619" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Restless legs</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="620" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Muscle contraction, involuntary</P>
</TD>
<TD>
<P>13/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="621" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Hyperkinesia</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="622" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Convulsion</P>
</TD>
<TD>
<P>4/100</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.19" NO="19" STUDIES="35">
<NAME>Irritability</NAME>
<OTHER_DATA ORDER="623" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>18/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="624" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>6/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="625" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>30/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="626" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>9/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="627" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="628" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>16/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="629" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Irritabillity</P>
</TD>
<TD>
<P>67/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="630" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Irritable</P>
</TD>
<TD>
<P>100/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="631" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Irritable</P>
</TD>
<TD>
<P>6/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="632" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>20/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="633" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="634" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Irritable</P>
</TD>
<TD>
<P>7/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="635" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>2/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="636" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>4/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="637" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>3/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="638" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="639" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>10/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="640" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>23/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="641" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>7/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="642" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>25/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="643" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>1/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="644" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>10/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="645" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>18/63</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="646" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>12/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="647" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>10/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="648" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Irritable</P>
</TD>
<TD>
<P>16/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="649" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>12/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="650" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>3/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="651" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>9/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="652" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>5/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="653" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>4/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="654" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>10/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="655" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>15/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="656" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>11/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="657" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>16/47</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.20" NO="20" STUDIES="14">
<NAME>Nervousness</NAME>
<OTHER_DATA ORDER="658" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>5/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="659" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>17/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="660" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="661" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>13/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="662" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>4/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="663" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>2/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="664" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>14/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="665" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>7/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="666" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>9/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="667" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>9/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="668" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>14/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="669" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>6/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="670" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>9/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="671" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Nervousness</P>
</TD>
<TD>
<P>2/61</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.21" NO="21" STUDIES="11">
<NAME>Nightmares</NAME>
<OTHER_DATA ORDER="672" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>2/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="673" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>1/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="674" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>8/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="675" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>1/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="676" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="677" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="678" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>1/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="679" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>4/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="680" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>1/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="681" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>10/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="682" STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>12/114</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.22" NO="22" STUDIES="14">
<NAME>Restlessness and agitation</NAME>
<OTHER_DATA ORDER="683" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>3/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="684" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>4/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="685" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>1/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="686" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>1/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="687" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>2/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="688" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>2/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="689" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>16/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="690" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>6/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="691" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>8/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="692" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>5/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="693" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>9/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="694" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Agitation</P>
</TD>
<TD>
<P>8/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="695" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Physical activity modifications</P>
</TD>
<TD>
<P>16/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="696" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Restlessness</P>
</TD>
<TD>
<P>5/19</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.23" NO="23" STUDIES="21">
<NAME>Sadness</NAME>
<OTHER_DATA ORDER="697" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="698" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>6/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="699" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Low mood</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="700" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Crying + sadness</P>
</TD>
<TD>
<P>17/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="701" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>3/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="702" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Sadness or unhappiness</P>
</TD>
<TD>
<P>69/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="703" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Sad</P>
</TD>
<TD>
<P>3/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="704" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>0/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="705" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>14/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="706" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>7/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="707" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Sad</P>
</TD>
<TD>
<P>1/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="708" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Sad</P>
</TD>
<TD>
<P>5/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="709" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>2/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="710" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Tearfulness</P>
</TD>
<TD>
<P>6/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="711" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>18/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="712" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Crying</P>
</TD>
<TD>
<P>13/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="713" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Sad</P>
</TD>
<TD>
<P>4/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="714" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>4/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="715" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>2/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="716" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>13/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="717" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Sadness</P>
</TD>
<TD>
<P>9/30</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.24" NO="24" STUDIES="4">
<NAME>Stares</NAME>
<OTHER_DATA ORDER="718" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Stares into space</P>
</TD>
<TD>
<P>3/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="719" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Stares a lot</P>
</TD>
<TD>
<P>8/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="720" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Stares</P>
</TD>
<TD>
<P>6/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="721" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Stares a lot or daydreams</P>
</TD>
<TD>
<P>7/31</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.25" NO="25" STUDIES="3">
<NAME>Excessive talking</NAME>
<OTHER_DATA ORDER="722" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Overly talkative</P>
</TD>
<TD>
<P>8/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="723" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Talks too much</P>
</TD>
<TD>
<P>5/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="724" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Speaking more</P>
</TD>
<TD>
<P>6/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.26" NO="26" STUDIES="4">
<NAME>Taciturnity ('talking too little')</NAME>
<OTHER_DATA ORDER="725" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Less talkative</P>
</TD>
<TD>
<P>4/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="726" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Talk less</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="727" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Talking little</P>
</TD>
<TD>
<P>6/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="728" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Talk less</P>
</TD>
<TD>
<P>9/31</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.27" NO="27" STUDIES="39">
<NAME>Tics</NAME>
<OTHER_DATA ORDER="729" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>3/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="730" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>2/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="731" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>3/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="732" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>27/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="733" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="734" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>100/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="735" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="736" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>35/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="737" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Tics or involuntary movements</P>
</TD>
<TD>
<P>0/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="738" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>0/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="739" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>6/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="740" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="741" STUDY_ID="STD-Golubchik-2011">
<TR>
<TD>
<P>Motor tics exacerbation</P>
</TD>
<TD>
<P>1/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="742" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Motor tics</P>
</TD>
<TD>
<P>1/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="743" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>0/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="744" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Motor tics</P>
</TD>
<TD>
<P>2/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="745" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="746" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Tics (new onset)</P>
</TD>
<TD>
<P>1/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="747" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>18/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="748" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>3/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="749" STUDY_ID="STD-Kim-2011">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>19/97</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="750" STUDY_ID="STD-Lakic-2012">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>3/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="751" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>6/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="752" STUDY_ID="STD-Miller_x002d_Horn-2008">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>2/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="753" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="754" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="755" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>4/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="756" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>7/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="757" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>2/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="758" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="759" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>7/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="760" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Tourette disorder</P>
</TD>
<TD>
<P>6/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="761" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="762" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="763" STUDY_ID="STD-Varley-2001">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>31/374</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="764" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Twitching</P>
</TD>
<TD>
<P>40/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="765" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="766" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>2/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="767" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Tics</P>
</TD>
<TD>
<P>1/16</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.28" NO="28" STUDIES="10">
<NAME>Isolation and lack of interest in others</NAME>
<OTHER_DATA ORDER="768" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Lack of interest</P>
</TD>
<TD>
<P>6/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="769" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Uninterested in others</P>
</TD>
<TD>
<P>39/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="770" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Uninterested in others</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="771" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Uninterested</P>
</TD>
<TD>
<P>4/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="772" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Uninterested</P>
</TD>
<TD>
<P>6/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="773" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Isolation</P>
</TD>
<TD>
<P>6/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="774" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Uninterested others</P>
</TD>
<TD>
<P>6/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="775" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Social withdrawal</P>
</TD>
<TD>
<P>6/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="776" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Being in own world</P>
</TD>
<TD>
<P>5/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="777" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Introversion (maybe isolation)</P>
</TD>
<TD>
<P>5/47</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.29" NO="29" STUDIES="3">
<NAME>'Zombie like' demeanour</NAME>
<OTHER_DATA ORDER="778" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Zombie like</P>
</TD>
<TD>
<P>3/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="779" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>Zombie like</P>
</TD>
<TD>
<P>18/245</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="780" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Apathy</P>
</TD>
<TD>
<P>4/407</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.30" NO="30" STUDIES="9">
<NAME>Somnolence</NAME>
<OTHER_DATA ORDER="781" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>1/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="782" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>5/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="783" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>3/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="784" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>8/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="785" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="786" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>6/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="787" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>7/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="788" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>1/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="789" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Somnolence</P>
</TD>
<TD>
<P>1/11</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.31" NO="31" STUDIES="3">
<NAME>Obsession</NAME>
<OTHER_DATA ORDER="790" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Obsessive behaviour</P>
</TD>
<TD>
<P>6/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="791" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Obsession</P>
</TD>
<TD>
<P>1/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="792" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Obsession</P>
</TD>
<TD>
<P>2/32</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.32" NO="32" STUDIES="2">
<NAME>Mood disorder</NAME>
<OTHER_DATA ORDER="793" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Mood disorder</P>
</TD>
<TD>
<P>49/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="794" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Emotional disorder of childhood</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.33" NO="33" STUDIES="2">
<NAME>Confusional state</NAME>
<OTHER_DATA ORDER="795" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Confusional state</P>
</TD>
<TD>
<P>1/262</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="796" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Sense of dopiness</P>
</TD>
<TD>
<P>13/128</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.34" NO="34" STUDIES="3">
<NAME>Sleep disorder</NAME>
<OTHER_DATA ORDER="797" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>6/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="798" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>9/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="799" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Sleep disorder</P>
</TD>
<TD>
<P>26/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.35" NO="35" STUDIES="2">
<NAME>Propensity to cry</NAME>
<OTHER_DATA ORDER="800" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Prone to cry</P>
</TD>
<TD>
<P>4/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="801" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Sudden crying</P>
</TD>
<TD>
<P>12/30</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.36" NO="36" STUDIES="2">
<NAME>Sedation</NAME>
<OTHER_DATA ORDER="802" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Sedation</P>
</TD>
<TD>
<P>4/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="803" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Sedation</P>
</TD>
<TD>
<P>4/19</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.37" NO="37" STUDIES="2">
<NAME>Daytime sleepiness</NAME>
<OTHER_DATA ORDER="804" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Daytime sleepiness</P>
</TD>
<TD>
<P>2/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="805" STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<TR>
<TD>
<P>Datime sleepiness</P>
</TD>
<TD>
<P>2/114</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.38" NO="38" STUDIES="1">
<NAME>Dysphoria</NAME>
<OTHER_DATA ORDER="806" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Dysphoria</P>
</TD>
<TD>
<P>2/134</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.39" NO="39" STUDIES="1">
<NAME>Logorrhoea</NAME>
<OTHER_DATA ORDER="807" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Loggorrhoea</P>
</TD>
<TD>
<P>1/129</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.40" NO="40" STUDIES="1">
<NAME>Impaired concentration</NAME>
<OTHER_DATA ORDER="808" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Impaired concentration</P>
</TD>
<TD>
<P>14/822</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.41" NO="41" STUDIES="1">
<NAME>Difficulty waking up</NAME>
<OTHER_DATA ORDER="809" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Difficult to wake up</P>
</TD>
<TD>
<P>7/28</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.42" NO="42" STUDIES="1">
<NAME>Urinary incontinence</NAME>
<OTHER_DATA ORDER="810" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Urinary incontinence</P>
</TD>
<TD>
<P>1/32</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.43" NO="43" STUDIES="1">
<NAME>Paralysis</NAME>
<OTHER_DATA ORDER="811" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Paralysis</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.44" NO="44" STUDIES="1">
<NAME>Affective disorder</NAME>
<OTHER_DATA ORDER="812" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Affective disorder</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.45" NO="45" STUDIES="1">
<NAME>Jumbled thoughts</NAME>
<OTHER_DATA ORDER="813" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Jumbled thoughts</P>
</TD>
<TD>
<P>1/154</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.46" NO="46" STUDIES="1">
<NAME>Bulimia</NAME>
<OTHER_DATA ORDER="814" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Bulimia</P>
</TD>
<TD>
<P>5/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.47" NO="47" STUDIES="1">
<NAME>Sleep late</NAME>
<OTHER_DATA ORDER="815" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Sleeping late</P>
</TD>
<TD>
<P>22/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.48" NO="48" STUDIES="1">
<NAME>Tooth grinding</NAME>
<OTHER_DATA ORDER="816" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Tooth grinding</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.49" NO="49" STUDIES="1">
<NAME>Tremor</NAME>
<OTHER_DATA ORDER="817" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Tremor</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.50" NO="50" STUDIES="1">
<NAME>Stuttering</NAME>
<OTHER_DATA ORDER="818" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Stuttering</P>
</TD>
<TD>
<P>4/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.51" NO="51" STUDIES="1">
<NAME>Flushing</NAME>
<OTHER_DATA ORDER="819" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Flushing</P>
</TD>
<TD>
<P>9/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.52" NO="52" STUDIES="1">
<NAME>Apathy</NAME>
<OTHER_DATA ORDER="820" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Apathy</P>
</TD>
<TD>
<P>6/541</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.53" NO="53" STUDIES="1">
<NAME>Abnormal behaviour</NAME>
<OTHER_DATA ORDER="821" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Abnormal behaviour</P>
</TD>
<TD>
<P>5/100</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.54" NO="54" STUDIES="1">
<NAME>Stereotypies</NAME>
<OTHER_DATA ORDER="822" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Stereotypies</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.55" NO="55" STUDIES="1">
<NAME>Quietness</NAME>
<OTHER_DATA ORDER="823" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Quietness</P>
</TD>
<TD>
<P>6/30</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.56" NO="56" STUDIES="1">
<NAME>EEG changes</NAME>
<OTHER_DATA ORDER="824" STUDY_ID="STD-Schmidt-2002">
<TR>
<TD>
<P>Pathologic</P>
</TD>
<TD>
<P>25/124</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.57" NO="57" STUDIES="1">
<NAME>Did not like themselves</NAME>
<OTHER_DATA ORDER="825" STUDY_ID="STD-Thorell-2009">
<TR>
<TD>
<P>Does not like him- or herself</P>
</TD>
<TD>
<P>10/79</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.58" NO="58" STUDIES="1">
<NAME>Sleep walking</NAME>
<OTHER_DATA ORDER="826" STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<TR>
<TD>
<P>Sleep walking</P>
</TD>
<TD>
<P>2/114</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.59" NO="59" STUDIES="1">
<NAME>Personality and behaviour disorders</NAME>
<OTHER_DATA ORDER="827" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Personality and behavior disorders</P>
</TD>
<TD>
<P>14/633</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.02.60" NO="60" STUDIES="1">
<NAME>Vertigo</NAME>
<OTHER_DATA ORDER="828" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Vertigo</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="39" SUBGROUPS="YES">
<NAME>Cardiovascular and respiratory system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.03.01" NO="1" STUDIES="7">
<NAME>Cough</NAME>
<OTHER_DATA ORDER="829" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Cough increased</P>
</TD>
<TD>
<P>7/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="830" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>5/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="831" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>38/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="832" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Cough increased</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="833" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="834" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>7/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="835" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Cough</P>
</TD>
<TD>
<P>10/166</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.02" NO="2" STUDIES="3">
<NAME>Pharyngolaryngeal pain</NAME>
<OTHER_DATA ORDER="836" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Pharyngolaryngeal pain</P>
</TD>
<TD>
<P>5/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="837" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Pharyngolaryngeal pain</P>
</TD>
<TD>
<P>19/326</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="838" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Pharyngolaryngeal pain</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.03" NO="3" STUDIES="5">
<NAME>Upper respiratory tract infection</NAME>
<OTHER_DATA ORDER="839" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Upper respiratory tract infection</P>
</TD>
<TD>
<P>40/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="840" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Upper respiratory tract infection</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="841" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Upper respiratory tract infection</P>
</TD>
<TD>
<P>11/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="842" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Upper respiratory tract infection</P>
</TD>
<TD>
<P>13/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="843" STUDY_ID="STD-Wiguna-2012">
<TR>
<TD>
<P>Upper respiratory tract infection</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.04" NO="4" STUDIES="6">
<NAME>Tachycardia</NAME>
<OTHER_DATA ORDER="844" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Heart races</P>
</TD>
<TD>
<P>2/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="845" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>24/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="846" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>3/326</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="847" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>1/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="848" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="849" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Tachycardia</P>
</TD>
<TD>
<P>8/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.05" NO="5" STUDIES="2">
<NAME>Abnormal ECG</NAME>
<OTHER_DATA ORDER="850" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Abnormal ECG</P>
</TD>
<TD>
<P>1/326</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="851" STUDY_ID="STD-Findling-2010">
<TR>
<TD>
<P>Abnormal ECG</P>
</TD>
<TD>
<P>30/162</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.06" NO="6" STUDIES="3">
<NAME>Nasal congestion</NAME>
<OTHER_DATA ORDER="852" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Nasal congestion</P>
</TD>
<TD>
<P>18/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="853" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Nasal congestion</P>
</TD>
<TD>
<P>1/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="854" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Nasal congestion</P>
</TD>
<TD>
<P>10/79</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.07" NO="7" STUDIES="3">
<NAME>Palpitation</NAME>
<OTHER_DATA ORDER="855" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Palpation</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="856" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Palpitations</P>
</TD>
<TD>
<P>8/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="857" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Palpation</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.08" NO="8" STUDIES="19">
<NAME>Systolic blood pressure</NAME>
<OTHER_DATA ORDER="858" STUDY_ID="STD-Cho-2012">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Non-significant increase following methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="859" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="860" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>The proportion of participants with a systolic blood pressure above the upper limit of normal (&gt; 123 mmHg) ranged from 1% to 10%, whereas 1.5% had an above normal systolic blood pressure at baseline</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="861" STUDY_ID="STD-Gadow-1995">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="862" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>100.6 mmHg (SD = 12.3)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="863" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Mean change from baseline: 0.1 mmHg (SD = 10.8)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="864" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>Drop in systolic blood pressure in 8/10 participants</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="865" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>113.8 mmHg (SD = 10.2)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="866" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>102.2 mmHg (SD = 9.89)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="867" STUDY_ID="STD-Lamberti-2015">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>105.4 mmHg (SD = 10.3)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="868" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>96.2 mmHg (SD = 14.0)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="869" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="870" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="871" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>105.3 mmHg (SD = 12.6)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="872" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>104.7 mmHg (SD = 8.10)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="873" STUDY_ID="STD-Winsberg-1982">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>103.1 mmHg (SD = no information)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="874" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>97 mmHg (SD = 10.8)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="875" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>96.6 mmHg (SD = 10.6)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="876" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>No changes</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.09" NO="9" STUDIES="16">
<NAME>Diastolic blood pressure</NAME>
<OTHER_DATA ORDER="877" STUDY_ID="STD-Cho-2012">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Non-significant, marginal increase after methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="878" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>69 mmHg (SD = 1.00)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="879" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="880" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>63.2 mmHg (SD = 10.9)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="881" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="882" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>Drop in diastolic blood pressure in 9/10 participants</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="883" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>75.2 mmHg (SD = 12.0)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="884" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>63.5 mmHg (SD = 7.90)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="885" STUDY_ID="STD-Lamberti-2015">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>59.2 mmHg (SD = 7.10)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="886" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>61.4 mmHg (SD = 13.7)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="887" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="888" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="889" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>66.9 mmHg (SD = 10.1)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="890" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>63.5 mmHg (SD = 12.0)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="891" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>64.6 mmHg (SD = 7.51)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="892" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>No change</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.10" NO="10" STUDIES="15">
<NAME>Pulse rate</NAME>
<OTHER_DATA ORDER="893" STUDY_ID="STD-Cho-2012">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="894" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>79 beats/min (SD = 1.00)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="895" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>79.9 beats/min (SD = 12.9)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="896" STUDY_ID="STD-Ilgenli-2007">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>88 beats/min (SD = 13.80)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="897" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>87.5 beats/min (SD = 6.10)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="898" STUDY_ID="STD-Kim-2015a">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>86.4 beats/min (SD = 11.2)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="899" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>80.4 beats/min (SD = 9.70)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="900" STUDY_ID="STD-Lamberti-2015">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>80.5 beats/min (SD = 15.5)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="901" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>95.5 beats/min (SD = 16.0)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="902" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="903" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>75.57 beats/min (SD = 7.33)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="904" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Increased</P>
</TD>
<TD>
<P>80.8 beats/min (SD = 9.80)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="905" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>82.5 beats/min (SD = 7.81)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="906" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>No difference </P>
</TD>
<TD>
<P>82.5 beats/min (SD = 7.81)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="907" STUDY_ID="STD-_x00d6_zcan-2004">
<TR>
<TD>
<P>Decreased</P>
</TD>
<TD>
<P>148.2 beats/min (SD = 29.70)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.11" NO="11" STUDIES="4">
<NAME>ECG-QT</NAME>
<OTHER_DATA ORDER="908" STUDY_ID="STD-Cho-2012">
<TR>
<TD>
<P>Non-significant change in QT and QRS</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="909" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>-</P>
</TD>
<TD>
<P>After 24 months, out of 77 patients treated with methylphenidate:</P>
<P>8 (10.4%) with altered ECG (electrocardiogram) at 24 months</P>
<P>11 (29.0%) with sinus bradycardia</P>
<P>12 (31.6%) with sinus tachycardia</P>
<P>6 (15.8%) with lengthened QTc</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="910" STUDY_ID="STD-Ilgenli-2007">
<TR>
<TD>
<P>Minimum QT of 317.00 (23.3)</P>
<P>Maximum QT of 373.7 (21.8)</P>
</TD>
<TD>
<P>After 2 hours:</P>
<P>Minimum QT of 322.3 (21.6)</P>
<P>Maximum QT of 361.8 (29.0)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="911" STUDY_ID="STD-Lamberti-2015">
<TR>
<TD>
<P>QTc of 407.6 (12.4)</P>
</TD>
<TD>
<P>After 2 hours: QTc of 409.8 (12.0)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.12" NO="12" STUDIES="1">
<NAME>Cold fingers</NAME>
<OTHER_DATA ORDER="912" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Cold fingers</P>
</TD>
<TD>
<P>13/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.13" NO="13" STUDIES="1">
<NAME>Sweating</NAME>
<OTHER_DATA ORDER="913" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Sweating</P>
</TD>
<TD>
<P>6/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.14" NO="14" STUDIES="1">
<NAME>Hypertension</NAME>
<OTHER_DATA ORDER="914" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>8/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.15" NO="15" STUDIES="1">
<NAME>Hypotension</NAME>
<OTHER_DATA ORDER="915" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Hypotension</P>
</TD>
<TD>
<P>3/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.16" NO="16" STUDIES="1">
<NAME>Respiratory, thoracic and mediastinal disorders</NAME>
<OTHER_DATA ORDER="916" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Respiratory, thoracic, and mediastinal disorders</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.03.17" NO="17" STUDIES="1">
<NAME>Proportion of patients with micro-nucleated (Mn) peripheral lymphocytes</NAME>
<OTHER_DATA ORDER="917" STUDY_ID="STD-Walitza-2009">
<TR>
<TD>
<P>(MN-Cells/1000 Cells mean)</P>
</TD>
<TD>
<P>Baseline: 4.90 (SD = 4.00)</P>
<P>6 months: 4.50 (SD = 3.50)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.04" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="102" SUBGROUPS="YES">
<NAME>Gastrointestinal system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.04.01" NO="1" STUDIES="79">
<NAME>Abdominal pain</NAME>
<OTHER_DATA ORDER="918" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>8/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="919" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="920" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>4/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="921" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>7/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="922" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>16/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="923" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>15/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="924" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>7/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="925" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Stomach pain</P>
</TD>
<TD>
<P>3/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="926" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="927" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>12/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="928" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Abdominal pain </P>
</TD>
<TD>
<P>6/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="929" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>12/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="930" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>22/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="931" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>1/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="932" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>14/287</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="933" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Upper abdominal pain</P>
</TD>
<TD>
<P>4/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="934" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Gastrointestinal pain</P>
</TD>
<TD>
<P>9/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="935" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Gastrointestinal pain</P>
</TD>
<TD>
<P>6/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="936" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>40/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="937" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>9/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="938" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>27/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="939" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="940" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>8/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="941" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>10/306</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="942" STUDY_ID="STD-Golubchik-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>1/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="943" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>2/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="944" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>9/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="945" STUDY_ID="STD-Greenhill-1983">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>4/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="946" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>14/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="947" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>4/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="948" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="949" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Stomach pain</P>
</TD>
<TD>
<P>6/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="950" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="951" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>6/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="952" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>33/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="953" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>9/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="954" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="955" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>11/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="956" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>7/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="957" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>6/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="958" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>12/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="959" STUDY_ID="STD-Lyon-2010">
<TR>
<TD>
<P>Stomach discomfort</P>
</TD>
<TD>
<P>2/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="960" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Gastrointestinal pain</P>
</TD>
<TD>
<P>2/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="961" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>2/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="962" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>28/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="963" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="964" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>8/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="965" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>5/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="966" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="967" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Stomach ache (abdominal pain)</P>
</TD>
<TD>
<P>19/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="968" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>15/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="969" STUDY_ID="STD-Peyre-2012a">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>7/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="970" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="971" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="972" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>7/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="973" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>4/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="974" STUDY_ID="STD-Schulz-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>9/145</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="975" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>4/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="976" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>3/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="977" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>20/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="978" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>10/72</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="979" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>10/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="980" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>4/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="981" STUDY_ID="STD-Thorell-2009">
<TR>
<TD>
<P>Stomach aches</P>
</TD>
<TD>
<P>2/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="982" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>1/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="983" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>15/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="984" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>9/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="985" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>5/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="986" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>17/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="987" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>29/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="988" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>45/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="989" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>9/220</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="990" STUDY_ID="STD-Wilens-2008">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>15/127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="991" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>6/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="992" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="993" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>3/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="994" STUDY_ID="STD-Zelnik-2015">
<TR>
<TD>
<P>Abdominal pain</P>
</TD>
<TD>
<P>36/128</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="995" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>140/1154</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="996" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Stomach ache</P>
</TD>
<TD>
<P>3/61</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.02" NO="2" STUDIES="4">
<NAME>Constipation</NAME>
<OTHER_DATA ORDER="997" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Constipation</P>
</TD>
<TD>
<P>10/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="998" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Constipation</P>
</TD>
<TD>
<P>4/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="999" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Constipation</P>
</TD>
<TD>
<P>2/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1000" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Constipation</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.03" NO="3" STUDIES="84">
<NAME>Decreased appetite</NAME>
<OTHER_DATA ORDER="1001" STUDY_ID="STD-Abbas-2006">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>2/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1002" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>12/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1003" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>5/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1004" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>8/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1005" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>27/221</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1006" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>26/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1007" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Decreased appetite </P>
</TD>
<TD>
<P>47/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1008" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>11/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1009" STUDY_ID="STD-Atzori-2009">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>27/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1010" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>13/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1011" STUDY_ID="STD-Chazan-2011">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>118/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1012" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>95/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1013" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>213/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1014" STUDY_ID="STD-Co_x015f_kun-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>3/7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1015" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>11/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1016" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>8/287</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1017" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Lack of appetite</P>
</TD>
<TD>
<P>5/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1018" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>8/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1019" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>3/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1020" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>Poor appetite</P>
</TD>
<TD>
<P>69/123</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1021" STUDY_ID="STD-El_x002d_Fiky-2014">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>12/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1022" STUDY_ID="STD-Famularo-1987">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>1/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1023" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>81/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1024" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>14/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1025" STUDY_ID="STD-Gau-2006">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>19/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1026" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>128/607</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1027" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>5/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1028" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>83/263</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1029" STUDY_ID="STD-Ghanizadeh-2013">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1030" STUDY_ID="STD-Golubchik-2011">
<TR>
<TD>
<P>Decrease in appetite</P>
</TD>
<TD>
<P>4/9</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1031" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Appetite suppression</P>
</TD>
<TD>
<P>5/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1032" STUDY_ID="STD-Green-2011">
<TR>
<TD>
<P>Poor appetite</P>
</TD>
<TD>
<P>13/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1033" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>23/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1034" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>19/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1035" STUDY_ID="STD-Hazell-2003">
<TR>
<TD>
<P>Appetite suppression</P>
</TD>
<TD>
<P>7/10</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1036" STUDY_ID="STD-Hulvershorn-2012">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>6/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1037" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1038" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>11/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1039" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Reduced appetite</P>
</TD>
<TD>
<P>26/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1040" STUDY_ID="STD-Jung-2007">
<TR>
<TD>
<P>Appetite loss</P>
</TD>
<TD>
<P>16/83</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1041" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>49/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1042" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>9/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1043" STUDY_ID="STD-Kim-2011">
<TR>
<TD>
<P>Poor appetite</P>
</TD>
<TD>
<P>22/97</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1044" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Anorexia</P>
</TD>
<TD>
<P>6/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1045" STUDY_ID="STD-Lakic-2012">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>68/68</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1046" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>31/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1047" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>13/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1048" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>7/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1049" STUDY_ID="STD-Maia-2008">
<TR>
<TD>
<P>Barkley decreased appetite</P>
</TD>
<TD>
<P>19/31</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1050" STUDY_ID="STD-Mayes-1994">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>14/63</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1051" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>31/61</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1052" STUDY_ID="STD-Miller_x002d_Horn-2008">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>2/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1053" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>4/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1054" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>17/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1055" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>11/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1056" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>9/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1057" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>66/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1058" STUDY_ID="STD-Perera-2010">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>51/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1059" STUDY_ID="STD-Peyre-2012a">
<TR>
<TD>
<P>Reduced appetite</P>
</TD>
<TD>
<P>9/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1060" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>7/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1061" STUDY_ID="STD-Poulton-2003">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>12/13</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1062" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>21/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1063" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>19/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1064" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>36/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1065" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>7/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1066" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>17/60</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1067" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>72/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1068" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>9/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1069" STUDY_ID="STD-Thorell-2009">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>21/79</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1070" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>9/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1071" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Appetite and nutrition disorders</P>
</TD>
<TD>
<P>68/689</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1072" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>32/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1073" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>77/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1074" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>21/39</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1075" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>38/200</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1076" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Appetite suppression</P>
</TD>
<TD>
<P>55/229</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1077" STUDY_ID="STD-Wilens-2008">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>35/127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1078" STUDY_ID="STD-Yalcin-2014">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>28/40</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1079" STUDY_ID="STD-Yatsuga-2014">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>3/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1080" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>27/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1081" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>7/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1082" STUDY_ID="STD-Zeni-2007">
<TR>
<TD>
<P>Decreased appetite</P>
</TD>
<TD>
<P>53/106</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1083" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>552/1154</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1084" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>Loss of appetite</P>
</TD>
<TD>
<P>16/123</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.04" NO="4" STUDIES="28">
<NAME>Decreased weight</NAME>
<OTHER_DATA ORDER="1085" STUDY_ID="STD-Abbas-2006">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>2/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1086" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>6/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1087" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>7/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1088" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>25/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1089" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>3/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1090" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Decreased weight</P>
</TD>
<TD>
<P>5/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1091" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>Weight decrease</P>
</TD>
<TD>
<P>10/762</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1092" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>37/1426</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1093" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>4/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1094" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Weight decrease</P>
</TD>
<TD>
<P>3/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1095" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>0/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1096" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Decreased weight</P>
</TD>
<TD>
<P>33/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1097" STUDY_ID="STD-Grcevich-2001">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>3/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1098" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Weight decreased</P>
</TD>
<TD>
<P>3/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1099" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>2/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1100" STUDY_ID="STD-Johnson-2013">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>9/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1101" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Weight decrease</P>
</TD>
<TD>
<P>8/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1102" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>2/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1103" STUDY_ID="STD-Lakic-2012">
<TR>
<TD>
<P>Moderate loss of body weight</P>
</TD>
<TD>
<P>68/68</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1104" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>9/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1105" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>Weight decrease</P>
</TD>
<TD>
<P>1/105</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1106" STUDY_ID="STD-Sahin-2014">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>20/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1107" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>4/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1108" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Decreased weight</P>
</TD>
<TD>
<P>9/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1109" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>8/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1110" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>12/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1111" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>5/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1112" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>Weight loss</P>
</TD>
<TD>
<P>1/16</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.05" NO="5" STUDIES="8">
<NAME>Diarrhoea</NAME>
<OTHER_DATA ORDER="1113" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1114" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>2/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1115" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>3/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1116" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1117" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>7/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1118" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>1/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1119" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1120" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Diarrhoea</P>
</TD>
<TD>
<P>1/19</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.06" NO="6" STUDIES="9">
<NAME>Dry mouth</NAME>
<OTHER_DATA ORDER="1121" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>8/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1122" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>10/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1123" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>2/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1124" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1125" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>1/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1126" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1127" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>6/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1128" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>3/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1129" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Dry mouth</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.07" NO="7" STUDIES="3">
<NAME>Gastrointestinal adverse events</NAME>
<OTHER_DATA ORDER="1130" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Gastrointestinal disorders</P>
</TD>
<TD>
<P>6/247</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1131" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>Gastrointestinal upset</P>
</TD>
<TD>
<P>36/607</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1132" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Gastrointestinal symptomatology</P>
</TD>
<TD>
<P>9/633</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.08" NO="8" STUDIES="41">
<NAME>Nausea</NAME>
<OTHER_DATA ORDER="1133" STUDY_ID="STD-Abbasi-2011">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>5/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1134" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>2/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1135" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1136" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>4/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1137" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>14/101</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1138" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>7/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1139" STUDY_ID="STD-Barrickman-1995">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1140" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>15/230</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1141" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>2/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1142" STUDY_ID="STD-D_x00f6_pfner-2011a_x002c_-OBSEER">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>9/777</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1143" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1144" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>20/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1145" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1146" STUDY_ID="STD-Ghanizadeh-2013">
<TR>
<TD>
<P>Nausea + vomiting</P>
</TD>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1147" STUDY_ID="STD-Gucuyener-2003">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>11/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1148" STUDY_ID="STD-Guerreiro-1996">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1149" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>4/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1150" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>4/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1151" STUDY_ID="STD-I_x015f_eri-2007">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1152" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>9/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1153" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>4/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1154" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1155" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>10/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1156" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Vomiting + nausea + dyspepsia</P>
</TD>
<TD>
<P>4/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1157" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>5/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1158" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>5/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1159" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>16/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1160" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>0/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1161" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>4/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1162" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>32/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1163" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1164" STUDY_ID="STD-Schulz-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>8/145</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1165" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>9/116</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1166" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>11/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1167" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>1/17</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1168" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>17/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1169" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>13/260</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1170" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>7/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1171" STUDY_ID="STD-Yildiz-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>9/47</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1172" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>5/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1173" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Nausea</P>
</TD>
<TD>
<P>5/18</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.09" NO="9" STUDIES="3">
<NAME>Upset stomach</NAME>
<OTHER_DATA ORDER="1174" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Dyspepsia</P>
</TD>
<TD>
<P>6/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1175" STUDY_ID="STD-Hulvershorn-2012">
<TR>
<TD>
<P>Upset stomach</P>
</TD>
<TD>
<P>4/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1176" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Dyspepsia</P>
</TD>
<TD>
<P>13/103</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.10" NO="10" STUDIES="20">
<NAME>Vomiting</NAME>
<OTHER_DATA ORDER="1177" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>3/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1178" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>1/195</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1179" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>23/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1180" STUDY_ID="STD-Jafarinia-2012">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>3/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1181" STUDY_ID="STD-Kemner-2005-_x0028_FOCUS_x0029_">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>11/850</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1182" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>8/110</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1183" STUDY_ID="STD-Lee-2014">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>5/100</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1184" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>1/8</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1185" STUDY_ID="STD-Mohammadi-2010">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>2/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1186" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>3/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1187" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>2/20</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1188" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>7/103</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1189" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>5/66</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1190" STUDY_ID="STD-Silva-2004">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>6/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1191" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>9/205</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1192" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2004">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>2/155</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1193" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>6/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1194" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>6/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1195" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>1/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1196" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>Vomiting</P>
</TD>
<TD>
<P>4/18</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.11" NO="11" STUDIES="2">
<NAME>Dyspepsia</NAME>
<OTHER_DATA ORDER="1197" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Dyspepsia</P>
</TD>
<TD>
<P>6/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1198" STUDY_ID="STD-Cortese-2015">
<TR>
<TD>
<P>Dyspepsia</P>
</TD>
<TD>
<P>9/1426</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.12" NO="12" STUDIES="2">
<NAME>Gastroenteritis</NAME>
<OTHER_DATA ORDER="1199" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Gastroenteritis</P>
</TD>
<TD>
<P>0/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1200" STUDY_ID="STD-Wigal-2015">
<TR>
<TD>
<P>Gastroenteritis</P>
</TD>
<TD>
<P>4/200</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.13" NO="13" STUDIES="1">
<NAME>Increased appetite</NAME>
<OTHER_DATA ORDER="1201" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Increased appetite</P>
</TD>
<TD>
<P>1/65</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.04.14" NO="14" STUDIES="1">
<NAME>Xerostomia</NAME>
<OTHER_DATA ORDER="1202" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Xerostomia</P>
</TD>
<TD>
<P>12/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.05" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="YES">
<NAME>Musculoskeletal system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.05.01" NO="1" STUDIES="3">
<NAME>Chest pain</NAME>
<OTHER_DATA ORDER="1203" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Chest pain</P>
</TD>
<TD>
<P>0/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1204" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Chest pain</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1205" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Chest pain</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.02" NO="2" STUDIES="6">
<NAME>Height</NAME>
<OTHER_DATA ORDER="1206" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1207" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>128.7 cm (SD = 9.10)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1208" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>133.8 cm (SD = 14.81)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1209" STUDY_ID="STD-Vincent-1990">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>158.7 cm (SD = 10.2)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1210" STUDY_ID="STD-Wiguna-2012">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>0.55 cm (SD = no information)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1211" STUDY_ID="STD-Yalcin-2014">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>134.6 cm (SD = 12.32)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.03" NO="3" STUDIES="8">
<NAME>Weight</NAME>
<OTHER_DATA ORDER="1212" STUDY_ID="STD-Davari_x002d_Ashtiani-2010">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>Weight gain in 1/16 participants</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1213" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>38.4 kg (SD = 11.3)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1214" STUDY_ID="STD-Kim-2010">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>28.5 kg (SD = 6.40)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1215" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>40.7 kg (SD = 17.2)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1216" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>32.7 kg (SD = 14.7)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1217" STUDY_ID="STD-Vincent-1990">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Observed weight: 47.9 kg (SD = 10.3)</P>
<P>Expected weight: 48.1 kg (SD = 10.6)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1218" STUDY_ID="STD-Wiguna-2012">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>36.2 kg (SD = 11.9)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1219" STUDY_ID="STD-Yalcin-2014">
<TR>
<TD>
<P>Increased from baseline</P>
</TD>
<TD>
<P>Weight gain in 15/33 participants</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.04" NO="4" STUDIES="3">
<NAME>BMI</NAME>
<OTHER_DATA ORDER="1220" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Mean change from baseline: −0.3 kg/m<SUP>2</SUP> (SD = 0.70)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1221" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>18.2 kg/m<SUP>2</SUP> (SD = 4.74)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1222" STUDY_ID="STD-Yalcin-2014">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>Methylphenidate group: 18.1 kg/m<SUP>2</SUP> (SD = 2.76)</P>
<P>Untreated group: 17.8k kg/m<SUP>2</SUP> (SD = 2.71)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.05" NO="5" STUDIES="7">
<NAME>Height z score</NAME>
<OTHER_DATA ORDER="1223" STUDY_ID="STD-Bereket-2005">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1224" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.36 (SD = 1.21)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1225" STUDY_ID="STD-Moungnoi-2011">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.09 (SD = no information)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1226" STUDY_ID="STD-Poulton-2003">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.26 (SD = 0.82)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1227" STUDY_ID="STD-Poulton-2012">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.34 (SD = 0.81)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1228" STUDY_ID="STD-Schertz-1996">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = -0.1(SD = no information)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1229" STUDY_ID="STD-Spencer-1992">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = -0.23 (SD = 0.42)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.06" NO="6" STUDIES="5">
<NAME>Weight z score</NAME>
<OTHER_DATA ORDER="1230" STUDY_ID="STD-Bereket-2005">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>0.2 (SD = 1.04)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1231" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>0.26 kg (SD = 1.40)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1232" STUDY_ID="STD-Moungnoi-2011">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.01 (SD = no information)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1233" STUDY_ID="STD-Poulton-2003">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>Z score = 0.44 (SD = 0.97)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1234" STUDY_ID="STD-Schertz-1996">
<TR>
<TD>
<P>Decreased from baseline</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.07" NO="7" STUDIES="3">
<NAME>BMI z score</NAME>
<OTHER_DATA ORDER="1235" STUDY_ID="STD-Bereket-2005">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>After 14 months:</P>
<P>Age-adjusted SD = 0.71</P>
<P>Sex-adjusted SD = 0.65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1236" STUDY_ID="STD-Dubnov_x002d_Raz-2011">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1237" STUDY_ID="STD-Poulton-2012">
<TR>
<TD>
<P>No difference</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.08" NO="8" STUDIES="1">
<NAME>Increased mobility</NAME>
<OTHER_DATA ORDER="1238" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>Increased mobility</P>
</TD>
<TD>
<P>22/122</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.05.09" NO="9" STUDIES="1">
<NAME>Bone mineral density</NAME>
<OTHER_DATA ORDER="1239" STUDY_ID="STD-Lahat-2000">
<TR>
<TD>
<P><B>Quote:</B> "There was no significant difference between serum calcium, phosphorus or bone-specific alkaline phosphatase, urinary deoxypyridinoline, or bone mineral density in the two groups of children. No child deviated from his height percentile during the treatment period."</P>
</TD>
<TD>
<P>NA</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.06" NO="6" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES">
<NAME>Immune system</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.06.01" NO="1" STUDIES="5">
<NAME>Nasopharyngitis</NAME>
<OTHER_DATA ORDER="1240" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>5/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1241" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>6/150</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1242" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>2/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1243" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>24/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1244" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>8/25</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.02" NO="2" STUDIES="3">
<NAME>Pyrexia</NAME>
<OTHER_DATA ORDER="1245" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Fever</P>
</TD>
<TD>
<P>7/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1246" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>Fever</P>
</TD>
<TD>
<P>33/157</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1247" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>Pyrexia</P>
</TD>
<TD>
<P>17/166</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.03" NO="3" STUDIES="2">
<NAME>Allergies</NAME>
<OTHER_DATA ORDER="1248" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Allergies</P>
</TD>
<TD>
<P>3/154</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1249" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Pruritis</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.04" NO="4" STUDIES="3">
<NAME>Cold symptoms</NAME>
<OTHER_DATA ORDER="1250" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Cold symptoms</P>
</TD>
<TD>
<P>2/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1251" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Fever + flu syndrome</P>
</TD>
<TD>
<P>8/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1252" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>Flu-like symptoms</P>
</TD>
<TD>
<P>7/72</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.05" NO="5" STUDIES="5">
<NAME>Pharyngitis</NAME>
<OTHER_DATA ORDER="1253" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Pharyngitis</P>
</TD>
<TD>
<P>10/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1254" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>Pharyngitis</P>
</TD>
<TD>
<P>2/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1255" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Pharyngitis</P>
</TD>
<TD>
<P>6/541</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1256" STUDY_ID="STD-Kratochvil-2002">
<TR>
<TD>
<P>Pharyngitis</P>
</TD>
<TD>
<P>3/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1257" STUDY_ID="STD-Sangal-2006">
<TR>
<TD>
<P>Pharyngitis</P>
</TD>
<TD>
<P>7/79</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.06" NO="6" STUDIES="2">
<NAME>Viral infection</NAME>
<OTHER_DATA ORDER="1258" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Viral infection</P>
</TD>
<TD>
<P>18/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1259" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Viral infection</P>
</TD>
<TD>
<P>8/598</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.07" NO="7" STUDIES="3">
<NAME>Rash</NAME>
<OTHER_DATA ORDER="1260" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Rash</P>
</TD>
<TD>
<P>6/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1261" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Rash</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1262" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>Rash</P>
</TD>
<TD>
<P>4/110</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.08" NO="8" STUDIES="2">
<NAME>Rhinitis</NAME>
<OTHER_DATA ORDER="1263" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>5/76</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1264" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Rhinitis</P>
</TD>
<TD>
<P>8/541</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.09" NO="9" STUDIES="1">
<NAME>Ear disorders</NAME>
<OTHER_DATA ORDER="1265" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>Ear pain</P>
</TD>
<TD>
<P>3/57</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.10" NO="10" STUDIES="1">
<NAME>Fever</NAME>
<OTHER_DATA ORDER="1266" STUDY_ID="STD-Kordon-2011">
<TR>
<TD>
<P>Fever</P>
</TD>
<TD>
<P>9/541</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.06.11" NO="11" STUDIES="1">
<NAME>Infections</NAME>
<OTHER_DATA ORDER="1267" STUDY_ID="STD-Valdiz_x00e1_n-Us_x00f3_n-2013">
<TR>
<TD>
<P>Nonspecific pathogen</P>
</TD>
<TD>
<P>13/689</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.07" NO="7" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO">
<NAME>Urogenital system: enuresis</NAME>
<TR>
<TH>
<P>Symptom</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="1268" STUDY_ID="STD-Blader-2010">
<TR>
<TD>
<P>Enuresis </P>
</TD>
<TD>
<P>2/65</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1269" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>Enuresis</P>
</TD>
<TD>
<P>3/27</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1270" STUDY_ID="STD-Tom_x00e1_s-Vila-2010b">
<TR>
<TD>
<P>Enuresis</P>
</TD>
<TD>
<P>16/114</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-007.08" NO="8" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES">
<NAME>Other body systems</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-007.08.01" NO="1" STUDIES="2">
<NAME>Hair loss</NAME>
<OTHER_DATA ORDER="1271" STUDY_ID="STD-Abbas-2006">
<TR>
<TD>
<P>Hair loss</P>
</TD>
<TD>
<P>1/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1272" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Hair loss</P>
</TD>
<TD>
<P>3/71</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.02" NO="2" STUDIES="4">
<NAME>Skin problems</NAME>
<OTHER_DATA ORDER="1273" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>Skin disorder</P>
</TD>
<TD>
<P>1/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1274" STUDY_ID="STD-Khajehpiri-2014">
<TR>
<TD>
<P>Acne</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1275" STUDY_ID="STD-Pierce-2010">
<TR>
<TD>
<P>Application site erythema</P>
</TD>
<TD>
<P>2/71</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1276" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>Skin eruption</P>
</TD>
<TD>
<P>1/66</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.03" NO="3" STUDIES="1">
<NAME>Accidental injury</NAME>
<OTHER_DATA ORDER="1277" STUDY_ID="STD-Arnold-2004">
<TR>
<TD>
<P>Accidental injury</P>
</TD>
<TD>
<P>10/76</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.04" NO="4" STUDIES="1">
<NAME>Voice frequency</NAME>
<OTHER_DATA ORDER="1278" STUDY_ID="STD-Congologlu-2009">
<TR>
<TD>
<P>In conclusion, this clinical trial is the only study that has examined the effects of stimulant medication on vocal acoustic parameters in children with ADHD (attention deficit hyperactivity disorder), and evaluated a small sample on and off their clinical doses of methylphenidate. We suggest that methylphenidate decreases fundamental frequency in children with ADHD, but our findings should be replicated under blind drug administration and by supporting other vocal analyses</P>
</TD>
<TD>
<P>NA</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.05" NO="5" STUDIES="1">
<NAME>Hypersalivation</NAME>
<OTHER_DATA ORDER="1279" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>Hypersalivation</P>
</TD>
<TD>
<P>1/27</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.06" NO="6" STUDIES="1">
<NAME>Nasal bleeding</NAME>
<OTHER_DATA ORDER="1280" STUDY_ID="STD-Ghanizadeh-2013">
<TR>
<TD>
<P>Nasal bleeding</P>
</TD>
<TD>
<P>1/26</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-007.08.07" NO="7" STUDIES="1">
<NAME>Chromosomal aberration</NAME>
<OTHER_DATA ORDER="1281" STUDY_ID="STD-Witt-2008">
<TR>
<TD>
<P>% of cells with chromosomal abberations</P>
</TD>
<TD>
<P>Before: 0.48% (0.09). After: 0.46% (0.09)<BR />
Study population: 25</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Non-comparative studies: proportion of participants withdrawn from methylphenidate treatment due to non-serious adverse events</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-008.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="37" SUBGROUPS="NO">
<NAME>Proportion of participants withdrawn from methylphenidate treatment due to non-serious adverse events</NAME>
<TR>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="1282" STUDY_ID="STD-Arabgol-2015">
<TR>
<TD>
<P>2/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1283" STUDY_ID="STD-Arnold-2010">
<TR>
<TD>
<P>1/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1284" STUDY_ID="STD-Berek-2011">
<TR>
<TD>
<P>60/822</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1285" STUDY_ID="STD-Chou-2012a">
<TR>
<TD>
<P>26/521</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1286" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>10/310</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1287" STUDY_ID="STD-D_x00f6_pfner-2011b">
<TR>
<TD>
<P>4/113</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1288" STUDY_ID="STD-Efron-1997">
<TR>
<TD>
<P>1/125</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1289" STUDY_ID="STD-Faraone-2007a">
<TR>
<TD>
<P>45/268</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1290" STUDY_ID="STD-Findling-2010">
<TR>
<TD>
<P>13/162</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1291" STUDY_ID="STD-Garg-2014">
<TR>
<TD>
<P>7/33</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1292" STUDY_ID="STD-Gerwe-2009">
<TR>
<TD>
<P>43/306</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1293" STUDY_ID="STD-Greenberg-1987">
<TR>
<TD>
<P>1/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1294" STUDY_ID="STD-Guerreiro-1996">
<TR>
<TD>
<P>1/24</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1295" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>19/152</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1296" STUDY_ID="STD-Hong-2012">
<TR>
<TD>
<P>3/112</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1297" STUDY_ID="STD-Karabekiroglu-2008">
<TR>
<TD>
<P>8/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1298" STUDY_ID="STD-Khodadust-2012">
<TR>
<TD>
<P>1/15</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1299" STUDY_ID="STD-Kim-2014b">
<TR>
<TD>
<P>3/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1300" STUDY_ID="STD-Lee-2007">
<TR>
<TD>
<P>2/119</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1301" STUDY_ID="STD-Maayan-2009">
<TR>
<TD>
<P>3/11</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1302" STUDY_ID="STD-Na-2013">
<TR>
<TD>
<P>7/121</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1303" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>3/80</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1304" STUDY_ID="STD-Sobanski-2013">
<TR>
<TD>
<P>5/381</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1305" STUDY_ID="STD-Song-2012">
<TR>
<TD>
<P>8/143</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1306" STUDY_ID="STD-Su-2015">
<TR>
<TD>
<P>16/239</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1307" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>3/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1308" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>6/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1309" STUDY_ID="STD-Wang-2011">
<TR>
<TD>
<P>3/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1310" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>21/305</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1311" STUDY_ID="STD-Weber-2003">
<TR>
<TD>
<P>4/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1312" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>4/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1313" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>2/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1314" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>38/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1315" STUDY_ID="STD-Winsberg-1982">
<TR>
<TD>
<P>5/25</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1316" STUDY_ID="STD-Yildiz-2011">
<TR>
<TD>
<P>1/12</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1317" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>34/1447</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1318" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>5/73</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-008.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="57" SUBGROUPS="NO">
<NAME>Proportion of participants withdrawn from methylphenidate for unknown reasons</NAME>
<TR>
<TH>
<P>Adverse events/total number of participants</P>
</TH>
</TR>
<OTHER_DATA ORDER="1319" STUDY_ID="STD-Akhondzadeh-2003">
<TR>
<TD>
<P>4/14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1320" STUDY_ID="STD-Akhondzadeh-2004">
<TR>
<TD>
<P>2/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1321" STUDY_ID="STD-Altin-2013">
<TR>
<TD>
<P>30/204</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1322" STUDY_ID="STD-Amiri-2008">
<TR>
<TD>
<P>3/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1323" STUDY_ID="STD-Ardic-2014">
<TR>
<TD>
<P>21/122</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1324" STUDY_ID="STD-Bal_x00e1_zs-2011">
<TR>
<TD>
<P>3/37</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1325" STUDY_ID="STD-Barbaresi-2006">
<TR>
<TD>
<P>84/379</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1326" STUDY_ID="STD-Bereket-2005">
<TR>
<TD>
<P>58/72</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1327" STUDY_ID="STD-Chou-2012b">
<TR>
<TD>
<P>34/296</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1328" STUDY_ID="STD-Dirksen-2002">
<TR>
<TD>
<P>13/310</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1329" STUDY_ID="STD-Dittmann-2014">
<TR>
<TD>
<P>52/247</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1330" STUDY_ID="STD-El_x002d_Zein-2005">
<TR>
<TD>
<P>6/18</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1331" STUDY_ID="STD-Findling-2009">
<TR>
<TD>
<P>109/326</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1332" STUDY_ID="STD-Findling-2010">
<TR>
<TD>
<P>54/162</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1333" STUDY_ID="STD-Gadow-1995">
<TR>
<TD>
<P>7/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1334" STUDY_ID="STD-Galland-2010">
<TR>
<TD>
<P>2/30</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1335" STUDY_ID="STD-Gau-2008">
<TR>
<TD>
<P>13/137</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1336" STUDY_ID="STD-Germinario-2013">
<TR>
<TD>
<P>161/351</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1337" STUDY_ID="STD-Guerreiro-1996">
<TR>
<TD>
<P>2/24</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1338" STUDY_ID="STD-Haertling-2015">
<TR>
<TD>
<P>16/262</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1339" STUDY_ID="STD-Hammerness-2009">
<TR>
<TD>
<P>97/152</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1340" STUDY_ID="STD-Hong-2012">
<TR>
<TD>
<P>5/112</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1341" STUDY_ID="STD-Jensen-1999-_x0028_MTA_x0029_">
<TR>
<TD>
<P>29/144</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1342" STUDY_ID="STD-Kim-2011">
<TR>
<TD>
<P>5/102</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1343" STUDY_ID="STD-Kim-2014b">
<TR>
<TD>
<P>12/75</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1344" STUDY_ID="STD-Kim-2015a">
<TR>
<TD>
<P>49/86</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1345" STUDY_ID="STD-Klein-2004">
<TR>
<TD>
<P>9/129</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1346" STUDY_ID="STD-Lee-2009">
<TR>
<TD>
<P>6/144</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1347" STUDY_ID="STD-Lee-2012">
<TR>
<TD>
<P>22/93</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1348" STUDY_ID="STD-Li-2011">
<TR>
<TD>
<P>2/36</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1349" STUDY_ID="STD-McCracken-2016">
<TR>
<TD>
<P>6/69</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1350" STUDY_ID="STD-Mohammadi-2004">
<TR>
<TD>
<P>5/16</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1351" STUDY_ID="STD-Mohammadi-2012a">
<TR>
<TD>
<P>8/32</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1352" STUDY_ID="STD-Mohammadi-2012b">
<TR>
<TD>
<P>3/23</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1353" STUDY_ID="STD-Peyre-2012a">
<TR>
<TD>
<P>37/173</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1354" STUDY_ID="STD-Poulton-2003">
<TR>
<TD>
<P>6/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1355" STUDY_ID="STD-Remschmidt-2005">
<TR>
<TD>
<P>26/89</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1356" STUDY_ID="STD-Shang-2015">
<TR>
<TD>
<P>11/80</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1357" STUDY_ID="STD-Sobanski-2013">
<TR>
<TD>
<P>29/381</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1358" STUDY_ID="STD-Steele-2006">
<TR>
<TD>
<P>4/73</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1359" STUDY_ID="STD-Tasdelen-2015">
<TR>
<TD>
<P>2/22</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1360" STUDY_ID="STD-Walitza-2009">
<TR>
<TD>
<P>15/26</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1361" STUDY_ID="STD-Wang-2007">
<TR>
<TD>
<P>7/166</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1362" STUDY_ID="STD-Wang-2011">
<TR>
<TD>
<P>17/50</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1363" STUDY_ID="STD-Warshaw-2010">
<TR>
<TD>
<P>28/305</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1364" STUDY_ID="STD-Weber-2003">
<TR>
<TD>
<P>8/57</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1365" STUDY_ID="STD-Weiss-2007">
<TR>
<TD>
<P>3/90</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1366" STUDY_ID="STD-Wigal-2013">
<TR>
<TD>
<P>3/45</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1367" STUDY_ID="STD-Wilens-2005">
<TR>
<TD>
<P>140/407</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1368" STUDY_ID="STD-Wilens-2006">
<TR>
<TD>
<P>36/171</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1369" STUDY_ID="STD-Witt-2008">
<TR>
<TD>
<P>9/34</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1370" STUDY_ID="STD-Yalcin-2014">
<TR>
<TD>
<P>2/40</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1371" STUDY_ID="STD-Yang-2012">
<TR>
<TD>
<P>12/130</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1372" STUDY_ID="STD-Zarinara-2010">
<TR>
<TD>
<P>1/19</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1373" STUDY_ID="STD-Zheng-2011">
<TR>
<TD>
<P>202/1447</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1374" STUDY_ID="STD-Zheng-2015">
<TR>
<TD>
<P>25/153</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1375" STUDY_ID="STD-_x00c7_etin-2015">
<TR>
<TD>
<P>7/73</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Patient reports/series: number of participants with serious adverse events</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-009.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="YES">
<NAME>Central nervous system</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-009.01.01" NO="1" STUDIES="12">
<NAME>Psychotic conditions</NAME>
<OTHER_DATA ORDER="1376" STUDY_ID="STD-Abali-2007">
<TR>
<TD>
<P>A 14-year-old girl with diagnoses of ADHD (attention deficit hyperactivity disorder), major depression and conduct disorder. During her treatment with methylphenidate of 20 mg/day and fluoxetine of 20 mg/day, she developed visual and auditory hallucinations. It may be concluded that it is possible that methylphenidate may cause hallucinations in patients treated simultaneously with fluoxetine</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1377" STUDY_ID="STD-Aguilera_x002d_Albesa-2010">
<TR>
<TD>
<P>2 case reports of the appearance of hallucinations a few hours after methylphenidate ingestion in an 8-year-old boy (extended-release methylphenidate of 18 mg/day, given once daily for 2 days) and a 6-year-old girl (extended-release methylphenidate of 10 mg/day for 3 days and 20 mg/day for 1 day, given once a day). Both diagnosed with ADHD according to criteria in the DSM-IV (<I>Diagnostic and Statistical Manual, Fourth Edition</I>) and with IQs (intelligence quotients) &gt; 85. These case reports suggest an individual susceptibility to psychotic symptoms after taking methylphenidate. This adverse event is considered idiosyncratic, extraordinary and unpredictable</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1378" STUDY_ID="STD-Co_x015f_kun-2008">
<TR>
<TD>
<P>A paediatric patient who developed tactile and visual hallucinations with the combination of osmotic release oral system (OROS) methylphenidate and fluoxetine.</P>
<P>Comments from the study authors: In conclusion, we think that the causative agent was the combination of both medications rather than either medication alone. However, in either situation, it is important to note that this distressing side effect may occur even in the absence of underlying psychotic or substance-related disorders, and clinicians' awareness is important in this issue, particularly in cases where polypharmacy is considered</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1379" STUDY_ID="STD-Goetz-2011">
<TR>
<TD>
<P>A case report of nocturnal visual hallucinations during methylphenidate treatment. A girl with ADHD and ODD (oppositional defiant disorder) experienced a 3-hour episode of nocturnal complex bizarre visual hallucinations when treated with 18 mg of OROS methylphenidate. Nocturnal polysomnography performed 2 weeks later revealed REM (rapid eye movement) sleep reduction (17%) and fragmentation. 2 episodes of confusional arousals were recorded. This finding is typical of parasomnia associated with NREM sleep – disorder of arousal. It is hypothesized that this pre-existing sleep impairment represents a factor of vulnerability to methylphenidate sleep side effects</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1380" STUDY_ID="STD-Gross_x002d_Tsur-2004">
<TR>
<TD>
<P>3 children with ADHD, who were treated with low doses of methylphenidate and who developed complex visual and haptic hallucinations</P>
<P>Comments from the study authors: The causal role of methylphenidate in the development of hallucinations was based on their appearance after ingestion of the drug, resolving after its withdrawal, and the absence of psychiatric comorbidity that could explain such phenomena. In 1 patient, the hallucinations reappeared after an inadvertent re-challenge. Because methylphenidate is a widely used, well-studied, and safe pharmacologic agent, physicians who prescribe methylphenidate should be aware of even rare adverse manifestations occurring at therapeutic doses</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1381" STUDY_ID="STD-Halevy-2009">
<TR>
<TD>
<P>Several days after initiation of treatment: visual hallucinations of rats, accompanied by some tactile hallucinations. Only present during the time the patient was under the influence of methylphenidate and disappeared thereafter; immediate complete resolution upon discontinuation of the drug. Reintroduction of metyhlphenidate treatment after 2 days resulted in same complex visual hallucinations, with immediate complete resolution upon discontinuation of the drug</P>
<P>Key conclusions of the study authors: In our case, the occurrence of hallucinations after a very low dose of methylphenidate on 2 occasions may suggest an idiosyncratic reaction. The phenomenon might also be explained by a drug-induced dysfunction of the monoamine transmitters. Given the wide use of methylphenidate, clinicians should be aware of this possible side effect</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1382" STUDY_ID="STD-Irmak-2014">
<TR>
<TD>
<P>A case report of phobias and visual hallucinations during methylphenidate treatment in a 9-year-old boy. OROS methylphenidate gradually titrated up to 1 mg/kg.</P>
<P>Methylphenidate prescribed at initial ADHD diagnosis and then withdrawn following the onset of phobias and visual hallucinations, as well as lack of improvement in attention problems</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1383" STUDY_ID="STD-Mino-1999">
<TR>
<TD>
<P>A case report on methylphenidate-induced psychosis in an adolescent with hyperkinetic disorder; use of methylphenidate for 1 month. Three weeks after starting methylphenidate (10 mg/day), the mother reported by telephone that the patient seemed depressed. Dose of methylphenidate was reduced to 5 mg/day. A week later the patient visited the clinic. The therapist diagnosed her condition as a depressive state and discontinued methylphenidate. Six weeks after discontinuation of methylphenidate she was diagnosed with a schizophrenic-like psychotic state, due to symptoms of delusions of reference and persecution, delusional mood, silly smile and thought block. There was no evident hallucination. The patient took antipsychotic medication for 2 months and her psychotic symptoms disappeared</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1384" STUDY_ID="STD-Porfirio-2011">
<TR>
<TD>
<P>3 years after start of methylphenidate treatment: An episode of complex visual hallucinations (dramatic scenes appearing before going to sleep, sometimes during the day after ingestion of methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1385" STUDY_ID="STD-Rashid-2007">
<TR>
<TD>
<P>A case report of intensified somatic hallucinations during dose increase of methylphenidate treatment in a 10-year-old boy with a chronic pattern of somatization, which evolved into overt somatic hallucinations with an increase in methylphenidate dosage. This pattern of somatization was retrospectively recognized as partial somatic hallucinations</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1386" STUDY_ID="STD-Shibib-2009">
<TR>
<TD>
<P>A report of four cases of psychosis during methylphenidate treatment</P>
<P>Key conclusion of the study authors: Psychosis is an important, unpredictable side effect of stimulant medication. Symptoms resolve with discontinuation of treatment. Reemergence of ADHD symptoms are rapid and re-challenge is often indicated. It would be advisable for all professionals involved in the care and treatment of patients with ADHD to receive mental health training to aid the early recognition and appropriate management of such side effects</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1387" STUDY_ID="STD-Tom_x00e1_s-Vila-2010a">
<TR>
<TD>
<P>After two weeks of 50% immediate-release and 50% extended-release methylphenidate: visual hallucinations (insects on hands, feet, abdomen and thorax), with associated itching, initiated two hours after ingestion and ceased five hours after. Discontinuation of methylphenidate and initiation of risperidone resulted in no visual hallucinations. No re-administration of methylphenidate due to ethical reasons</P>
<P>Key conclusions of the study authors: This is the first case report of visual hallucinations caused by 50% immediate-release and 50% extended-release methylphenidate, which is not surprising considering the relative recent appearance of this preparation on the market</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.01.02" NO="2" STUDIES="2">
<NAME>Seizures</NAME>
<OTHER_DATA ORDER="1388" STUDY_ID="STD-Feeney-1997">
<TR>
<TD>
<P>First-reported seizure in a patient being treated with methylphenidate and sertraline combined</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1389" STUDY_ID="STD-Hemmer-2001">
<TR>
<TD>
<P>Reported seizures in a boy aged six, and two girls aged six and seven, receiving 0.3 to 1 mg/kg/day of methylphenidate for six weeks, 10 and three months, respectively</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.01.03" NO="3" STUDIES="1">
<NAME>Cerebral arteritis</NAME>
<OTHER_DATA ORDER="1390" STUDY_ID="STD-Trugman-1988">
<TR>
<TD>
<P>Key conclusions of the study authors: Cerebral arteritis and infarction were caused by chronic use of oral methylphenidate. The Cerebrospinal fluid (CSF) profile and angiogram support the diagnosis of inflammatory arteritis, yet laboratory evaluation revealed no identifiable cause. In the six years since the stroke, while not on methylphenidate, there has been no evidence of active central nervous system or systemic vasculitis</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.01.04" NO="4" STUDIES="3">
<NAME>Self-harm and suicidal behaviour</NAME>
<OTHER_DATA ORDER="1391" STUDY_ID="STD-Arun-2014">
<TR>
<TD>
<P>2 case reports with 2 children having suicidal ideation</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1392" STUDY_ID="STD-G_x00f6_kce-2015">
<TR>
<TD>
<P>Reported a 12-year-old boy who made a suicide attempt after switching from 27 mg to 36 mg of OROS methylphenidate: The patient reported irritable mood when he took the first dose of 36 mg of long-acting methylphenidate. This might be the cause of the suicide attempt. He had a full recovery after withdrawal from methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1393" STUDY_ID="STD-Strandell-2007">
<TR>
<TD>
<P>Reported concerns about suicidal behaviour, including suicide, based on information retrieved from the WHO Collaborating Centre for International Drug Monitoring (Uppsala, Sweden). A total of 116 reports of methylphenidate related to "suicide attempts", although this term was not explicitly defined. The data included reports of methylphenidate and atomoxetine</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.01.05" NO="5" STUDIES="1">
<NAME>Death</NAME>
<OTHER_DATA ORDER="1394" STUDY_ID="STD-T_x00f8_ll_x00f8_fsrud-2006">
<TR>
<TD>
<P>A case report of death caused by heart failure (acute dilated cardiomyopathy) during methylphenidate treatment</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.01.06" NO="6" STUDIES="1">
<NAME>Dyskinesia</NAME>
<OTHER_DATA ORDER="1395" STUDY_ID="STD-Yilmaz-2013">
<TR>
<TD>
<P>Involuntary movements started about 5 hours after taking MPH. Lip-licking, lip-smacking and tongue-rolling movements. Dyskinetic tongue movements inside and outside the mouth and involuntary bilateral arm swinging while sitting and standing. Opening and closing his fingers without complete extension. Occasional repetitive movements of the feet, such as beating them against each other while sitting. About 15 hours after MPH intake both hand-mouth movements and excessive mobility had significantly resolved. Dyskinetic symptoms had completely disappeared on the second day of hospitalization, and the patient was discharged</P>
<P>Key conclusions of the study authors: This case is reported to emphasize the potential side effects of methylphenidate, individual differences in drug sensitivities, and drug-receptor interactions via different mechanisms</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-009.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES">
<NAME>Cardiovascular and respiratory system</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-009.02.01" NO="1" STUDIES="2">
<NAME>Cardiovascular events</NAME>
<OTHER_DATA ORDER="1396" STUDY_ID="STD-Munk-2015">
<TR>
<TD>
<P>The present case demonstrates that myocardial infarction can occur due to methylphenidate exposure in a healthy 11-year-old boy, without other known cardiovascular risk factors. 54 mg methylphenidate/day. Treatment duration was 2 years. Cardiac arrest followed exercise without prior complaints of chest pain/discomfort or shortness of breath. A week before the event, he had a short episode of tachycardia. Clinical examination showed that the myocardial infarct was not acute but had occurred weeks prior to the cardiac arrest. It was thought to be due to thinning of the myocardium and an adversely remodelled left ventricle. A pacemaker was inserted and methylphenidate treatment was discontinued. The only apparent cause, after extensive assessment, appeared to be the high-dose methylphenidate treatment (maximum recommended) over an extended period</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1397" STUDY_ID="STD-Nymark-2008">
<TR>
<TD>
<P>A case report of serious cardiomyopathy during MPH treatment. Serious cardiovascular adverse effects (hypoxia and dyspnoea requiring hospitalisation) after 11 months of MPH treatment. Clinical examination showed signs of liver failure, renal failure and heart failure</P>
<P>Comments of the study authors (Nymark et al): With a BMI of 40 our patient had extreme obesity. The hyperdynamic circulation, with increased cardiac output, was thought to be a compensatory adaptation to increased adipose tissue. This may have led to non-ischaemic dilated cardiomyopathy at the expense of left ventricular hypertrophy and remodeling as may occur in severely obese subjects (McGavock et al 2006). This is, however, unlikely as the only cause in our young patient. Human obesity is also characterized by sympathetic nervous system activation (Eikelis and Esler 2005). A possible obesity-linked susceptibility to the toxic effect of methylphenidate could therefore play a role in the development of DCM in our patient, especially with regards to the short treatment time of one year</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-009.02.02" NO="2" STUDIES="1">
<NAME>Hypertension</NAME>
<OTHER_DATA ORDER="1398" STUDY_ID="STD-Saieh-2004">
<TR>
<TD>
<P>A case report of hospitalisation due to hypertension during MPH treatment</P>
<P><U>Serious adverse events</U></P>
<P>72-hour hospitalisation, emergency unit</P>
<P>Abdominal pain for four days prior to hospitalisation, intermittent accentuation (hours), no other symptoms</P>
<P>Secondary hypertension: Persistent hypertension (158/88-170/105, pulse: 78-98 bpm). Normal physical examination. Normal eye fundus and normal cardiological examination</P>
<P>Discontinuation of MPH: Hypertensive treatment only necessary for 24 hours</P>
<P>Normal blood pressure after one week</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-009.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Gastrointestinal system: hepatoxicity</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_DATA ORDER="1399" STUDY_ID="STD-Bernhard-2009">
<TR>
<TD>
<P>A hepatotoxic reaction</P>
<P>Liver enzymes were elevated prior to therapy. Vomiting starting 5 weeks after onset of methylphenidate therapy and increased within the next 3 days. Abdominal pain increased in intensity. Liver transaminases elevated over 30 times of the normal level, CK level also increased</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-009.04" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO">
<NAME>Urogenital system: priapism</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_DATA ORDER="1400" STUDY_ID="STD-Cakin_x002d_Memik-2010">
<TR>
<TD>
<P>A case report of a 14-year-old male with attention deficit hyperactivity disorder (ADHD) who presented with priapism after administration of immediate-release methylphenidate. When the usage of immediate-release methylphenidate was terminated, priapism spontaneously disappeared</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1401" STUDY_ID="STD-Schwartz-2004">
<TR>
<TD>
<P>A case report of a 15-year-old white male with ADHD (inattention subtype) who experienced painful erections two weeks after beginning sustained release (OROS) MPH and repeated painful erections that increased with increased doses (during withdrawal). MPH use for more than 2 months. It is likely that withdrawal from OROS methylphenidate was the cause of this adolescent boy's priapism. He was embarrassed to disclose the problem to an adult until it became quite severe. It is possible that this adverse event is under-reported due to sensitivity and embarrassment of young people</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>Patient reports/series: number of participants with non-serious adverse events</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Central nervous system: movement-related outcomes</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.01.01" NO="1" STUDIES="2">
<NAME>Tics</NAME>
<OTHER_DATA ORDER="1402" STUDY_ID="STD-Adrian-2001">
<TR>
<TD>
<P>A case report of a boy aged 10 years referred to a tertiary neurodevelopmental assessment clinic for a second opinion on the management of his ADHD. He started with 20 mg/day of methylphenidate at 7 years of age and gradually increased to 40 mg/day, for 2 to 3 years. Both motor and vocal tics started at 40 mg/day of methylphenidate and subsided spontaneously after a year of treatment</P>
<P>Authors' conclusion: The clinically explosive outbursts of tics were coincident with a period of treatment with methylphenidate for the treatment of ADHD (attention deficit hyperactivity disorder) and should not be mistaken for a symptom of the disorder</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1403" STUDY_ID="STD-Chandler-1989">
<TR>
<TD>
<P>Reported non-serious adverse events. After a month, the child's mother reported motor and phonic tics again. He was treated first with methylphenidate and then with nortriptyline. With both drugs he manifested severe facial grimacing and phonic tics; apparently, the tics had only occurred in the past when the child was treated with methylphenidate. It is, however, very difficult to attribute the tics to methylphenidate with any certainty because of the common co-occurrence of tics in children and young people with ADHD</P>
<P>Key conclusions of the study authors: Side effects, such as hypomania, hyperreflexia and diaphoresis, have been reported in patients being treated with a combination of a monoamine oxidase inhibitor and tryptophan. By itself, L-tryptophan may be mildly sedating. In light of such a favourable side-effect profile, combined with no evidence for adverse interaction with stimulants, and at least some rationale from preclinical research, it should be investigated further as a means of alleviating some of the harsh consequences of psychostimulant treatment in ADHD</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.01.02" NO="2" STUDIES="3">
<NAME>Involuntary movements or dyskinesia</NAME>
<OTHER_DATA ORDER="1404" STUDY_ID="STD-Hollis-2007">
<TR>
<TD>
<P>A case report of acute and transient dyskinesia occurring within hours of taking modified-release methylphenidate (Concerta XL) in a stimulant-naïve 7-year-old boy who had recently stopped taking risperidone</P>
<P>Key conclusions of the study authors: This report is the first of a dyskinesia occurring after a single first dose of methylphenidate in a previously stimulant-naïve patient after neuroleptic withdrawal. It is also the first to link this effect with modified-release methylphenidate. The dyskinesia described here consisted of both brief tic-like movements</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1405" STUDY_ID="STD-Machado-2010">
<TR>
<TD>
<P>Choreoathetoid movements of orofacial muscles, arms and legs, with transient dystonic postures of the right arm induced by a single dose of extended-release methylphenidate. Author believes that the immediate response ensuing chlorpromazine prescription argues in favour of a specific role for dopamine receptor antagonists in methylphenidate-induced chorea</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1406" STUDY_ID="STD-McLaren-2010">
<TR>
<TD>
<P>The patient experienced spasmodic muscular contractions of his jaw. The staff noticed a forceful jaw closure, contraction and tension, and the patient had difficulties opening his mouth. 50 mg of diphenhydramine was administered intramuscularly and the patient could open his mouth within 30 minutes and with no further dystonia</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES">
<NAME>Central nervous system: mood disorders</NAME>
<TR>
<TH>
<P>Description </P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.02.01" NO="1" STUDIES="3">
<NAME>Depression and disturbed mood</NAME>
<OTHER_DATA ORDER="1407" STUDY_ID="STD-Hechtman-2011">
<TR>
<TD>
<P>A case report about a 5-year-old boy. MPH use for around a year. Reported non-serious adverse events. In late afternoon and early evening, he became very emotional, with frequent crying, marked irritability and many tantrums. The emotional side effects subsided after he discontinued methylphenidate treatment</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1408" STUDY_ID="STD-Mino-1999">
<TR>
<TD>
<P>3 weeks after starting on 10 mg/day of methylphenidate, the mother reported by telephone that the patient seemed depressed. The dose of methylphenidate was reduced to 5 mg/day. A week later the patient visited the clinic. The therapist diagnosed her condition as a depressive state and discontinued methylphenidate. 6 weeks after discontinuation of methylphenidate, she was diagnosed with a schizophrenic-like psychotic state, due to symptoms of delusions of reference and persecution, delusional mood, silly smile and thought block. There was no evident hallucination. The patient took antipsychotic medication for 2 months and her psychotic symptoms disappeared</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1409" STUDY_ID="STD-Niederhofer-2009">
<TR>
<TD>
<P>An 11-year-old boy received 20 mg/day of methylphenidate for 2 months, which led to depressed mood and appetite loss</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.02.02" NO="2" STUDIES="2">
<NAME>Irritability</NAME>
<OTHER_DATA ORDER="1410" STUDY_ID="STD-Hechtman-2011">
<TR>
<TD>
<P>A case report about a boy, who became very emotional, with frequent crying episodes, marked irritability and many tantrums when treated with methylphenidate; methylphenidate was used for around a year</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1411" STUDY_ID="STD-Sabuncuoglu-2007">
<TR>
<TD>
<P>3 case reports of hyperactivity and irritability during switch from risperidone to methylphenidate</P>
<P>Case 1: Methylphenidate introduced 2 days after abrupt discontinuation of 1 mg/day of risperidone (8 months), and produced agitation, irritability, vigilance, and violent behavior. No dyskinetic movements. Methylphenidate was discontinued and the adverse events disappeared. After a 6-week long, drug-free period, methylphenidate was reintroduced at 15 mg/day. No adverse events were observed</P>
<P>Case 2: Methylphenidate introduced after discontinuation of 1 mg/day of risperidone (2 years), and produced a near manic state, irritability, agitation, racing thoughts, and distractibility. No dyskinetic movements. Methylphenidate was discontinued and the adverse events disappeared. After a couple of months, methylphenidate was reintroduced at 15 mg/day and was well-tolerated</P>
<P>Case 3: Methylphenidate introduced after a 1-week medication-free interval after treatment with 1 mg of risperidone, and produced irritability, agitation and discomfort. Methylphenidate was discontinued and the adverse events disappeared. The patient did not retry the medication</P>
<P>Key conclusions of the study authors: This report of 3 patients draws attention to a unique condition that arises in switching from an atypical antipsychotic to stimulant medication. A drug-free interval is recommended in switching from risperidone to methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.02.03" NO="3" STUDIES="2">
<NAME>Aggression</NAME>
<OTHER_DATA ORDER="1412" STUDY_ID="STD-Coignoux-2009">
<TR>
<TD>
<P>A case report of a 14-year-old boy receiving methylphenidate for 2 years who developed gestural stereotypies and verbal aggressiveness towards his parents whilst on methylphenidate treatment</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1413" STUDY_ID="STD-Niederhofer-2011">
<TR>
<TD>
<P>A case series describing adverse effects (xerostomia, aggression and emotional instability) among children taking methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.02.04" NO="4" STUDIES="2">
<NAME>Mania/euphoria</NAME>
<OTHER_DATA ORDER="1414" STUDY_ID="STD-Corrigall-1996">
<TR>
<TD>
<P>A case report of methylphenidate euphoria in an 11-year-old boy diagnosed with hyperkinetic disorder</P>
<P>Key conclusions of the study authors: Methylphenidate euphoria can occur in young prepubertal children and this may lead to abuse of medication</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1415" STUDY_ID="STD-Ghanizadeh-2009">
<TR>
<TD>
<P>Mother and nursery teacher complained about increased hyper-talkativity starting about 45 minutes after taking medication. The increased hyper-talkativity continued for about 3–4 hours. They scored the hyper-talking as 7–9 on a 1–10 visual analogue scale. Re-challenge was conducted many times (more than 20 times) and hyper-talking reoccurred after every time he took the medication</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES">
<NAME>Central nervous system: sleep problems</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.03.01" NO="1" STUDIES="1">
<NAME>Disturbed sleep</NAME>
<OTHER_DATA ORDER="1416" STUDY_ID="STD-Langevin-2012">
<TR>
<TD>
<P>A controlled before-and-after study. Methylphenidate used to treat ADHD (attention deficit hyperactivity disorder), from December (time 1) to June (time 2)</P>
<P>Key conclusions of the study authors: The principal results support the study's hypothesis and show a significant baseline difference (P = 0.008) between the nocturnal movements of children with ADHD and those of children in the control group</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.03.02" NO="2" STUDIES="2">
<NAME>Other sleep problems</NAME>
<OTHER_DATA ORDER="1417" STUDY_ID="STD-Arun-2014">
<TR>
<TD>
<P>A case report of a child whose sleep was impaired for 1 night after receiving methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1418" STUDY_ID="STD-Co_x015f_kun-2010">
<TR>
<TD>
<P>A case series of 7 children who experience side effects during methylphenidate treatment:</P>
<P>Sleep problems: n = 4</P>
<P>Worsening of pre-existing sleep problems: n = 2</P>
<P>No worsening of pre-existing sleep problems: n = 1</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.04" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES">
<NAME>Central nervous system: voice and speech disorders</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.04.01" NO="1" STUDIES="1">
<NAME>Voice problems</NAME>
<OTHER_DATA ORDER="1419" STUDY_ID="STD-Yalcin-2012">
<TR>
<TD>
<P>Teacher and family observed disturbance of voice quality, hoarseness, bifurcation-strain and over vibration of voice. The symptoms began on the first day of treatment with methylphenidate. Hoarseness and reduction in the voice amplitude was evident during the first visit to a psychiatric out-hospital clinic. No symptoms were observed by parents or during the psychiatric control on drug-free days. Experienced hoarseness when methylphenidate administered in the clinic. Voice quality returned to normal three hours after ingestion. Laryngitis or other organic conditions causing hoarseness were not observed in physical and endoscopic examination. There were no important side effects with discontinuation of methylphenidate and administration of atomoxetine</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.04.02" NO="2" STUDIES="1">
<NAME>Stuttering</NAME>
<OTHER_DATA ORDER="1420" STUDY_ID="STD-Alpaslan-2015">
<TR>
<TD>
<P>A case report of a 7-year-old boy who developed stuttering associated with the use of methylphenidate; received 10 mg/daily of short-acting methylphenidate. 10 days after beginning treatment with short-acting methylphenidate, the client began to stutter. Treatment was stopped. 1 week later, the patient's speech was back to normal. 4 weeks later atomoxetine treatment was started with no recurrence of stuttering</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.05" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Central nervous system: other specific adverse events</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.05.01" NO="1" STUDIES="1">
<NAME>Anorexia</NAME>
<OTHER_DATA ORDER="1421" STUDY_ID="STD-Findling-1996">
<TR>
<TD>
<P>A case report about an 11-year-old girl who experienced transient side effects after receiving methylphenidate: mild and transient anorexia, transient weight loss of 2 kg observed in the initiation of methylphenidate therapy</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.05.02" NO="2" STUDIES="2">
<NAME>Obsessive compulsive disorder (OCD) symptoms</NAME>
<OTHER_DATA ORDER="1422" STUDY_ID="STD-Co_x015f_kun-2011">
<TR>
<TD>
<P>A case report of OCD symptoms during methylphenidate treatment. Decreased appetite and initial headache with 18 mg/day of osmotic-controlled release oral delivery system (OROS) methylphenidate, and obsessive-compulsive symptoms, decreased appetite, facial grimace, and nail picking/biting with 27 mg/day of OROS methylphenidate. Gradual disappearance of symptoms, although still subsyndromal obsessive-compulsive symptoms, with discontinuation of medication. Mild facial grimace and similar obsessive-compulsive symptoms with re-administration of 27 mg/day of OROS methylphenidate. After three weeks, total score of 21 on Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1423" STUDY_ID="STD-Woolley-2003">
<TR>
<TD>
<P>Obsessions and compulsions with anxiety. DSM-IV (<I>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edtion</I>) diagnosis of OCD. Washing hands excessively, which was accompanied by checking rituals, reassurance seeking, and emetophobia. When methylphenidate was withdrawn, OCD symptoms decreased rapidly but increased when methylphenidate was reintroduced</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.05.03" NO="3" STUDIES="1">
<NAME>Headache</NAME>
<OTHER_DATA ORDER="1424" STUDY_ID="STD-Mize-2004">
<TR>
<TD>
<P>A case report of headache and mild depression during methylphenidate treatment</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.05.04" NO="4" STUDIES="1">
<NAME>EEG changes</NAME>
<OTHER_DATA ORDER="1425" STUDY_ID="STD-Dupuy-2008">
<TR>
<TD>
<P>A controlled before-and-after study investigating the effects of stimulants on EEG (electroencephaolography) coherence in 9 girls with ADHD (attention deficit hyperactivity disorder); intrahemispheric and interhemispheric coherences in girls with ADHD who were treated with stimulant medication. Girls had elevated frontal coherence in all frequency bands</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.06" NO="6" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES">
<NAME>Cardiovascular and respiratory system</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.06.01" NO="1" STUDIES="1">
<NAME>Vasculopathy</NAME>
<OTHER_DATA ORDER="1426" STUDY_ID="STD-Yu-2010">
<TR>
<TD>
<P>These case reports raise the concern that adverse effects in the peripheral vascular system of children and adolescents may be associated with psychostimulant treatment</P>
<P>Patient 1: Tachycardia at age 11 while taking Concerta, 54 mg/d. Vasculopathy at age 16. His hands and feet were a continuous blue colour on his hands and fingers, which increased in frequency in cold weather. He was diagnosed with "decreased circulation but not Raynaud's syndrome". Occured when the Concerta dose was increased from 54 mg/d to 90 mg/d in 3 months with the same Focalin (dexmethylphenidate) dose (10mg/d)</P>
<P>Patient 2: Vasculopathy. First diagnosed with Raynaud's syndrome with finger pain and colour changes during a neurology consultation at age 10 years. At age 12 years had diffuse erythema of both earlobes, the fingers of both hands, and the toes of his left foot. Tics at age 10 years but not clear if these were present prior to treatment for ADHD</P>
<P>Patient 4: Vasculopathy. After taking Focalin for a year, he developed persistent curling of the toes of both feet. In addition, he had reddish and purple colour changes in his hands and feet with cold exposure that lasted for 20 minutes. No associated pain and only rare paraesthesia. At age 10 years, toes 2, 3 and 4 of both feet were held in a flexed position ("curled toes"), and there was skin discolouration and excoriation</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.06.02" NO="2" STUDIES="1">
<NAME>Cardiovascular problems</NAME>
<OTHER_DATA ORDER="1427" STUDY_ID="STD-Karaman-2010">
<TR>
<TD>
<P>A case report of a 15-year old boy with ADHD who developed pulmonary arterial hypertension (PAH) during OROS MPH treatment</P>
<P>Fourth day of treatment: The patient began to experience occasional episodes of slightly shortness of breath. Continued over several months. Not associated with either exercise or anxiety</P>
<P>At 18th month of treatment: Fainting. Normal weight. No sign of allergy, hypersensitivity, or sleep apnoea. Mean pulmonary arterial pressure of 40 mmHg at rest, otherwise no pathological findings from extensive testing (Examination: clear lungs, no murmurs, rubs, or gallops, and otherwise unremarkable. Laboratory tests, including C-reactive protein, thyroid and liver function tests, electrolytes. Blood gases, antinuclear antibodies, D-dimers, chest X-ray, ventilation–perfusion scintigraphy, electrocardiography, respiratory function tests. Echography. Transthoracic echocardiogram: normal except for the mean pulmonary arterial pressure). No use of any other drug. No history of alcohol and substance use and no symptoms or signs of MPH misuse (intravenous injection). The personal and familial histories were also negative for pulmonary or cardiovascular diseases</P>
<P>Discontinuation of OROS-MPH, one month: free of symptoms</P>
<P>After the fourth week of discontinuation: Mean pulmonary arterial pressure of 28 mmHg</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.06.03" NO="3" STUDIES="1">
<NAME>Bleeding</NAME>
<OTHER_DATA ORDER="1428" STUDY_ID="STD-Grossman-1985">
<TR>
<TD>
<P>A case report of a 7-year-old girl on methylphenidate treatment who developed idiopathic trombocytopenic purpura (ITP). Physical examination at the paediatric outpatient department found countless petechiae over the entire dermal surface. Numerous areas of purpura were noted, especially over her buttocks and extremities. Multiple areas of buccal mucosal and gingival bleeding with a large hematoma presented on the left lateral surface of her tongue. Clotted blood was seen in her nostrils and ear canals bilaterally. Bone marrow aspiration showed normal to increased megakaryocytes with normal red and white cell precursors. MPH was stopped and the patient was admitted. After one week of treatment for the condition, her petechia had begun to fade. She did not start on MPH again. There has been no recurrence of petechiae or bruising one year later. MPH use for seven months prior to presentation of ITP</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.06.04" NO="4" STUDIES="1">
<NAME>Tachycardia</NAME>
<OTHER_DATA ORDER="1429" STUDY_ID="STD-Gracious-1999">
<TR>
<TD>
<P>A case report of atrioventricular (AV) nodal re-entrant tachycardia during stimulant treatment</P>
<P>Key conclusions of the study authors: Stimulant medication may evoke onset of AV nodal tachyarrhythmias in patients who have the potential to develop them, possibly in combination with a selective serotonergic reuptake inhibitor</P>
<P>Comments from the study authors: The cardiologist consulted believed this patient had a structural vulnerability of genetic etiology for the arrhythmia which was then precipitated by the stimulant</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.07" NO="7" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Gastrointestinal system</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.07.01" NO="1" STUDIES="5">
<NAME>Loss of appetite</NAME>
<OTHER_DATA ORDER="1430" STUDY_ID="STD-Agarwal-2008">
<TR>
<TD>
<P>A case report of the combination of atomoxetine and methylphenidate treatment of ADHD. Non-serious adverse events: decreased appetite and delayed onset in sleep</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1431" STUDY_ID="STD-Co_x015f_kun-2009a">
<TR>
<TD>
<P>IR MPH, 10–20 mg/day, co-medication: valproate 400 mg/day. Decreased appetite, no weight decrease</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1432" STUDY_ID="STD-Ghanizadeh-2008a">
<TR>
<TD>
<P>A case report of decrease in appetite during treatment with MPH</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1433" STUDY_ID="STD-Rappaport-2004">
<TR>
<TD>
<P>A case report of side effects during MPH treatment in a 14-year-old boy with ADHD and a number of other co-morbid conditions (whilst taking immediate-release MPH)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1434" STUDY_ID="STD-Yalcin-2012">
<TR>
<TD>
<P>Significant appetite loss, drowsiness, disturbance of voice and hoarseness Disturbance of voice and hoarseness occurred on everyday since the first day of the medication. The symptoms started short after the single morning dose and decreased gradually to dinner time and disappeared before bedtime. Drug-free days: no symptoms. Otolaryngology consultation: no organic pathology was detected with respect to clinical and endoscopic observation. Discontinuation of MPH and prescription of atomoxetine: no symptom of hoarseness and disturbance of voice quality</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.07.02" NO="2" STUDIES="1">
<NAME>Nausea and vomiting</NAME>
<OTHER_DATA ORDER="1435" STUDY_ID="STD-Rappaport-2004">
<TR>
<TD>
<P>A case report of side effects during MPH treatment in a 14-year-old boy with ADHD and a number of other co-morbid conditions (whilst taking extended-release MPH: Concerta)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.08" NO="8" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Musculoskeletal system: growth</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_DATA ORDER="1436" STUDY_ID="STD-Holtkamp-2002">
<TR>
<TD>
<P>A case report of growth impairment during MPH treatment</P>
<P>Key conclusions of the study authors: One may conclude that some children are at risk of serious growth decrement when treated with MPH. The growth of children should thus be monitored carefully, even if there are no alarming gastrointestinal side effects from MPH. We found that the determination of growth velocity was a sensitive marker for the evaluation of growth impairment in our patient</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.09" NO="9" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO">
<NAME>Immune system: allergic reactions</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_DATA ORDER="1437" STUDY_ID="STD-Confino_x002d_Cohen-2005">
<TR>
<TD>
<P>A case report of pruritic maculopapular skin rash developing during MPH treatment. The rash improved with antihistamines and re-challenge at a lower dose caused the reappearance, though less severe, of the rash. Desensitisation through graded exposure of MPH in incremental doses prevented further rash development</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1438" STUDY_ID="STD-Vashi-2011">
<TR>
<TD>
<P>After 8 months of using an MPH patch the patient presented with pruritic dermatitis. She had itchy, burning, red lesions. Symptoms began on her hip at the area of patch placement, then progressively spread to her arms, legs, abdomen, and back. MPH discontinued: Symptoms lasted for 2 months. First and second patch test. Re-tested with MPH patch: Nine days after the first test the patient presented with recall reaction, characterized by a return of the original pruritic dermatitis to her entire back, similar to the eruption that had occurred months previously after therapeutical use of MPH patch. Avoidance of MPH patches: symptom-free</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.10" NO="10" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Urogenitial system</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.10.01" NO="1" STUDIES="1">
<NAME>Testicular failure</NAME>
<OTHER_DATA ORDER="1439" STUDY_ID="STD-Ramasamy-2014">
<TR>
<TD>
<P>A case report of testicular failure possibly associated with chronic use of Methylphendiate. The patient was 20 years old with treatment duration of approximately 17 years with voluntary cessation a few years ago. Dosage varied with age. The patient's complaint was initially delayed puberty. He complained of high-pitched voice, lack of libido, low energy level, chronic fatigue and poor erectile function. The patient was advised to begin testosterone supplementation. The patient described in the case study seemed to exhibit characteristics related to the effects of chronic use of methylphenidate on development of human reproductive function. The unknown effects of methylphenidate are currently being studied, but as can be seen, one should exercise caution and patients should be followed closely when prescribing methylphenidate. However, because the developmental changes that occurred in the human participant occurred over a number of years of treatment with methylphenidate, there is very little information about the patient's condition and how it developed during that period of time</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.10.02" NO="2" STUDIES="1">
<NAME>Sexual adverse events</NAME>
<OTHER_DATA ORDER="1440" STUDY_ID="STD-Co_x015f_kun-2009b">
<TR>
<TD>
<P>Case 1: Treated with 10-30 mg/day of immediate-release methylphenidate and experienced initial headache and nausea. Treated with 18 mg/day osmotic-controlled release oral delivery system (OROS) methylphenidate and experienced emotional side effects (sense of nervousness in the chest, occasional emotional numbing), multiple daily erections (unrelated to sexual stimuli, painless and without ejaculations), occurring a few hours after ingesting methylphenidate and lasting 5-10 minutes. No erections unrelated to sexual stimuli during a 1-week medication-free period. With re-administration of 35 mg/day OROS methylphenidate for 3 weeks, experienced re-emergence of erections of a longer duration compared with 18 mg/day of OROS methylphenidate, headache, nausea, and the same emotional side effects. No erections on drug-free days, and no erections with discontinuation of medication.</P>
<P>Case 2: Treated with 18 mg/day of OROS methylphenidate and experienced loss of appetite, headache, abdominal pain, sleep problems, and conjunctival injection. Headache and abdominal pain almost disappeared after 1 week. Also experienced hypersexual behaviours, with morning erections lasting 1 hour before ingestion of methylphenidate, and a weight loss of 1.5 kg within 2 months. On drug-free days had almost no hypersexual behaviour during the day and no erection the following morning. When treated with 10-20 mg/day of immediate-release methylphenidate, morning erections and hypersexual behaviours decreased dramatically, sleep and appetite problems improved mildly, and there was no conjunctival injection (after three weeks). There were, however, possible withdrawal symptoms (increased irritability and hyperactivity, getting tearful easily), several hours after each dosage.</P>
<P>Had no morning erections or hypersexual behaviours with discontinuation of OROS methylphenidate</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.10.03" NO="3" STUDIES="1">
<NAME>Incontinence</NAME>
<OTHER_DATA ORDER="1441" STUDY_ID="STD-Tang-2010">
<TR>
<TD>
<P>Side effects reported by the mother: IR-MPH, 10 mg, no side effects. OROS-MPH, 18 mg/d, no side effects. OROS-MPH, 36 mg/d, double incontinence; stool incontinence (every day, frequent during daytime) and urinary incontinence (almost every day). The double incontinence completely resolved rapidly after the discontinuation of OROS methylphenidate 36 mg</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.10.04" NO="4" STUDIES="2">
<NAME>Enuresis</NAME>
<OTHER_DATA ORDER="1442" STUDY_ID="STD-Ghanizadeh-2008b">
<TR>
<TD>
<P>A case report of nocturnal enuresis during MPH treatment</P>
<P>Non-serious adverse events</P>
<P>MPH, titrated to 20 mg/day: Nocturnal enuresis</P>
<P>Discontinuation of MPH: enuresis stopped immediately</P>
<P>MPH, when titrated to 20 mg/day: Immediate re-occurence of nocturnal enuresis</P>
<P>Discontinuation of MPH: enuresis stopped immediately</P>
<P>MPH, when titrated to 20 mg/day: Immediate re-occurence of nocturnal enuresis</P>
<P>Discontinuation of MPH: enuresis stopped immediately</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1443" STUDY_ID="STD-Williamson-2011">
<TR>
<TD>
<P>Two case reports showing resolution of enuresis when treated with MPH</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-010.11" NO="11" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Other body systems</NAME>
<TR>
<TH>
<P>Description</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-010.11.01" NO="1" STUDIES="2">
<NAME>Skin reactions</NAME>
<OTHER_DATA ORDER="1444" STUDY_ID="STD-Cohen-1992">
<TR>
<TD>
<P>Case 1: </P>
<P>5 days of MPH treatment: hospitalisation due to two days of severe swelling and redness of the scrotum The skin eruption resolved spontaneously four days after MPH was discontinued. Two weeks later, 18 hour after MPH retrial, the same skin eruption of the scrotum was documented. Discontinued once again, and followed by a complete resolution of the rash in four days<BR />
Case 2:</P>
<P>7 days of MPH treatment: Six hours of severe swelling and redness of the scrotum. Discontinuation of MPH was followed by a complete resolution of rash in three days.Rechallenge with MPH two months later was followed by the same skin eruption of the scrotum within two days. Complete resolution was seen after drug withdrawal</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1445" STUDY_ID="STD-Co_x015f_kun-2009a">
<TR>
<TD>
<P>OROS-MPH 18 mg/day, co-medication: valproate 400 mg/day. Maculopapular pruritic skin eruptions on the patient's neck, arms, and legs, one week after starting OROS MPH treatment</P>
<P>Re-administering of OROS-MPH 18 mg/day, comedication: gabapentine 300 mg/day. Same skin eruptions with same severity, nine days after starting OROS-MPH treatment again</P>
<P>Discontinuation of medication: skin lesions abated within the next several weeks</P>
<P>Restart of IR-MPH, 10–20 mg/day, co-medication gabapentine 300 mg/day, four months: no skin eruptions</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.11.02" NO="2" STUDIES="1">
<NAME>Problems with sedation</NAME>
<OTHER_DATA ORDER="1446" STUDY_ID="STD-Ririe-1997">
<TR>
<TD>
<P>A case report (6-year-old boy) on unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents: There could be a potential risk of unwanted interactions between methylphenidate and anaesthetic agents. Based on the observations from the case report, a more detailed and systematic investigation of methylphenidate in patients undergoing anaesthesia or sedation is warranted</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-010.11.03" NO="3" STUDIES="2">
<NAME>Eye problems</NAME>
<OTHER_DATA ORDER="1447" STUDY_ID="STD-Ghanizadeh-2008c">
<TR>
<TD>
<P>Photophobia, occurring a few days after initiation of MPH treatment</P>
<P>Discontinuation of MPH at least three times: no symptoms of photophobia</P>
<P>Re-administration of MPH: immediate reoccurrence of photophobia</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="1448" STUDY_ID="STD-Lewis-2012">
<TR>
<TD>
<P>This report concluded stimulant medication (MPH) should not be withheld in patients with glaucoma as long as intraocular pressure (IOP) remains well controlled</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES />
<FEEDBACK />
<APPENDICES />
<EXTENSIONS />
</COCHRANE_REVIEW>
